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Abstract
Introduction: Little is known about hospital-acquired infections (HAI) in developing countries 
although surgical site infections (SSI) are thought to be a particular problem. The aim of the work in 
this thesis was to describe three different forms of HAI (SSI, hospital-acquired bacteraemia in 
children, transmission of MRSA in hospital inpatients) in hospitals in sub-Saharan Africa and to make 
changes, where possible, to prevent their occurrence.
Methods: A literature review on the subject of SSI in sub-Saharan Africa was conducted as part of 
the preliminary investigation. To study the occurrence of SSI in Thika Hospital in Kenya, SSI 
surveillance was established at this site and we subsequently implemented a change in the use of 
surgical antibiotic prophylaxis at this hospital. The occurrence of MRSA amongst inpatients in Thika 
Hospital was measured in a cross-sectional study and the occurrence of hospital-acquired bacteraemia 
in children in Kilifi Hospital, Kenya was measured using surveillance data from 2002-2009.
Results: The epidemiological characteristics of the SSI surveillance programme in Thika Hospital 
were examined including: the consistency of parameter scoring by surgeons and anaesthetists; the 
sensitivity and specificity of telephone-based post-discharge surveillance; the performance of risk 
indicators in predicting SSI after major Obstetric+Gynaecological surgery.
The process, outcome and balancing effects of changing the use of surgical antibiotic prophylaxis at 
Thika Hospital were evaluated, showing that there was rapid and sustained uptake of pre-operative 
antibiotic prophylaxis use and a more gradual reduction in use of post-operative antibiotics. There was 
evidence of a modest reduction in the risk of superficial SSI, and an overall reduction in the use of 
antibiotics, with accompanying cost and time savings.
The risk, rate, aetiology and morbidity and mortality impacts associated with paediatric hospital- 
acquired bacteraemia in Kilifi Hospital were examined. In a subsequently published correspondence 
questions regarding Coagulase-negative staphylococci, premature infants and competing risks were 
addressed.
MRSA carriage rate amongst inpatients in Thika Hospital was estimated. This organism was 
relatively rare, and carriage was largely confined to patients with bums. All MRSA isolates obtained 
were in the ST239-t037 clone, suggesting within-hospital transmission.
Conclusion: The work of this thesis suggests that the problem of hospital-acquired infections in sub- 
Saharan Africa is substantial, although there are some simple and achievable steps that can be taken to 
reduce their occurrence.
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Preface
This PhD thesis consists of a collection of research papers, both published and as-yet- 
unpublished, relating to the subject of hospital-acquired infections in sub-Saharan Africa. Although 
these papers all address the same broad subject area, they are intended to be able to stand alone as 
independent research contributions. Thus there are several repetitions of descriptions and definitions 
which I hope will not prove too burdensome for the reader. My aim is to “tell the story” of my journey 
through this research area over the past three years, so that it presents my contributions to this field as 
a coherent body of work. Each paper is prefaced with a title page that gives the publication status of 
the paper, as of January 2013.
Chapter 1 gives an introduction to this thesis by providing the historical backdrop to this 
subject area and describing the sequence of research papers in some detail. Chapters 2 to 4 give three 
papers relating to Surgical Site Infections -  the order of these three papers reflects the progressive 
stages of the research process, from reviewing the literature, to establishing research methods and 
finally to attempting to measure the effects of a deliberately introduced change in practice. Chapters 5 
relates to an observational study of paediatric nosocomial bacteraemia, with one major paper 
accompanied by a subsequently published correspondence. Chapter 6 reports a study into the extent 
and typing of MRS A and S. aureus carriage in a single hospital. Chapter 7 provides a final discussion 
and outlines future directions for research, policy and clinical practice in this area.
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Chapter 1: Introduction
Chapter 1. Introduction
1.1. A brief historical preamble
Histories o f the epidemiology of hospital-acquired (nosocomial) infections normally 
begin with reference to the work o f Ignaz Semmelweis, the 19 century Hungarian physician 
who deduced that contamination on the hands o f medical practitioners was transmitting the 
causative agent of puerpual fever between women in obstetric hospitals in Vienna. As is 
widely known, his contemporaries largely rejected his conclusions and Semmelweis was 
ultimately committed to an asylum. He died at the age o f 47 from septicaemia, thought to 
have come from a wound infection sustained in a beating from asylum guards. Posthumously, 
Semmelweis’ conclusions were vindicated by Pasteur’s confirmation o f the germ theory o f 
disease causation and Lister’s pioneering use of sterile surgery -  his legacies earn him the 
title “the father o f hospital epidemiology”.
This thesis focuses on nosocomial diseases in developing countries, and specifically 
in countries in sub-Saharan Africa, with the fieldwork reported from studies in two hospitals 
in Kenya. Therefore, a more appropriate place to begin a history o f nosocomial infections in 
Africa would be with one o f the earliest reports o f nosocomial disease transmission in this 
region -  which, like this thesis, is a tale o f two hospitals in Africa. Much of this information 
is drawn from reports from the WHO investigating teams in Sudan and Zaire (1-2).
In June and July 1976, in the town o f Nzara, Sudan (now South Sudan), close to the 
border with the Republic o f Zaire (now Democratic Republic o f Congo) and on the edge of 
an area o f tropical rain-forest, three employees in a cotton factory fell sick with a severe 
influenza-like illness. Although all three men were employees in the same section of the 
factory, their lifestyles were otherwise quite different and they lived well apart. The first two 
cases (YG and BZ) both lived with their families and had few contacts outside their homes. 
During their illnesses, they were both predominantly nursed by close family members, and 
both men developed extensive haemorrhagic complications and died within two weeks o f 
becoming ill. The brother o f YG developed similar symptoms approximately 10 days later, 
though he recovered from the illness. The wife o f BZ became ill and died five days after her 
husband. The third factory employee (PG) was a sociable bachelor living in the centre o f 
Nzara town. During his illness, he was visited by many friends, including Samir S and Sallah 
S (the sons o f a local merchant), and nursed by two women, HW and CB. The epidemic
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principally propagated from this point and subsequent investigations related 48 cases and 27 
deaths in Nzara to the infection in PG, usually involving close nursing or care of an infected 
individual. Notably, whilst all three primary cases were admitted to the small hospital in 
Nzara in the later stages of their illnesses, only a minority (26%) o f all the cases occurring in 
Nzara were themselves admitted to hospital. Ultimately, only two patients in Nzara (2/67;
3%) were associated with nosocomial acquisition o f infection.
The disease spread out from Nzara in various directions, including to the town of 
Maridi, 128km away, when Samir S was admitted to the Maridi Hospital in early August 
1976. Subsequently, AI, a nurse who had administered injections to Sallah S, in his home was 
also admitted to Maridi Hospital at the end o f August. Although the towns of Nzara and 
Maridi were o f similar sizes, the hospital in Maridi was a much larger teaching facility with 
approximately 230 staff members, plus a body of student nurses, whereas the hospital in 
Nzara was limited to a few admitted patients.
In Maridi Hospital in August 1976, staff members began to fall ill with the same 
disease and were themselves admitted to various different hospital wards -  in Maridi, almost 
three-quarters o f cases were admitted to hospital. The number of cases increased gradually 
until mid-September, and towards the end of the month there was a surge o f cases, mainly 
occurring amongst hospital staff. Before the outbreak could be recognized as such, there were 
infected, haemorrhagic patients in most of the hospital wards. At least one third of staff at 
Maridi Hospital became infected, including the doctor-in-charge and 61 of 154 nursing staff. 
In total, 41 staff members died, including all six medical assistants and over 40% of student 
nurses. Other patients, carers o f acutely ill patients and hospital visitors also were involved 
and seeded the infection out into the general community. The number o f cases declined in 
early October, possibly as a result o f the use o f protective clothing -  but supplies ran out in 
mid-October and this was followed by another surge in cases in late October and early 
November. At the end of October 1976, the WHO team arrived in Maridi with an ample 
supply o f disposable gowns, gloves, masks and other personal protective equipment -  and 
were able to instruct the remaining hospital staff on the use o f such clothing and its 
subsequent decontamination. The disease was, o f course, Ebola Virus Disease, which was 
named after a small river in Zaire, close to Yambuku where an outbreak of disease occurred 
from September 1976 onwards. Although the outbreak in Zaire was initially thought to have 
been spread from Sudan by truck drivers -  there was extensive commercial traffic between 
the two areas -  it later appeared that the Sudan and Zaire Ebola viruses were of different
9
Chapter 1: Introduction
species. The disease was deliberately named after a virtually unknown river as it was felt to 
be insensitive to follow the convention of naming the organism after the town or country 
from whence the first specimens were obtained (3).
The epidemic curves of disease in the two towns in Sudan are shown below in Figure 1-1:
Disease cases in Nzara and Maridi in 1976
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Figure 1-1: Epidemic curves for outbreaks in two towns in Sudan 
Overall, more than three times as many Ebola cases occurred in Maridi as in Nzara 
and almost half of all cases (93/213, 44%) in Maridi were inferred to have the hospital as a 
source. In the words of the WHO report, “The [Maridi] hospital served as both the focus and 
amplifier o f infection... the hospital served as an efficient amplifier from which the virus was 
disseminated throughout the town" (l).W hy did the larger, better-staffed hospital serve as the 
more efficient amplifier of infection? Firstly, as already mentioned, in Maridi, patients were 
much more likely to be admitted to hospital than in Nzara, though this trend may have 
reversed once it became evident to the local population that the hospital was the source of 
disease. Secondly, patients generally only remained admitted in Nzara Hospital for a few 
days, whereas patients in Maridi Hospital often remained admitted for more than two weeks. 
Thirdly, the original report described differential transmission risk by type o f contact -  
touching an infected patient was associated with a much lower risk of transmission (5/23:
10
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23%) than performing nursing care (39/48: 81%). We can speculate that in Maridi Hospital, 
greater efforts were probably being made to provide full nursing care to patients, with the 
result that more staff were being exposed to the level o f contact required for transmission.
The concept o f barrier nursing would almost certainly not have existed in Maridi Hospital at 
that time and it is evident (from the allocation of incoming cases to different wards) that in 
the early stages o f the outbreak, patients were not being cohorted by symptoms on admission. 
Finally, there was probably more widespread access to and use o f needles, syringes and 
intravenous access devices in Maridi Hospital and some of these devices may have been 
shared between patients -  this was the principal mode of Ebola transmission around 
Yambuku Hospital in Zaire (2). Needlestick and other sharps-related injuries may also have 
played a part in transmission of Ebola from patients to healthcare workers in Maridi Hospital 
-  this was retrospectively discovered to have occurred in Zaire in the early 1970’s (4).
In healthcare epidemiology, outbreaks of highly pathogenic organisms with clearly 
recognisable clinical syndromes represent the most visible and alarming form o f nosocomial 
infections. Whilst occurrences of such outbreaks always gamers much public attention -  at 
the time o f writing in August 2012, an Ebola outbreak in Kampala, Uganda was causing 
major concern in hospitals in Kenya -  these outbreaks have generally affected relatively 
small numbers o f people, and have rarely lasted more than a few weeks. In developing 
countries, other nosocomial infections whose impact is less immediately visible might be 
having a larger, though less well-recognised impact. Recently, estimations o f disease 
transmission resulting from unsafe injections have suggested that this has played a major role 
in the transmission o f several important bloodboume viruses including Hepatitis B, Hepatitis 
C and HIV (5). In sub-Saharan Africa in 1999, it was estimated from a modelling approach 
that unsafe injections might cause between 780,000 and 1.5 million Hepatitis B infections, 
between 255,000 and 510,000 Hepatitis C infections and between 51,000 and 102,000 HIV 
infections annually (6) -  though some of these injection-related infections would have been 
occurring outside o f the formal healthcare sector. On this basis, we might suspect that whilst 
reported outbreaks o f noscomial infection in sub-Saharan African are particularly notorious, 
these probably only represent the “tip o f the iceberg” o f hospital-acquired infections (HAI) in 
the region.
Bloodbome viruses are one part o f the “rare-but-severe” end o f the nosocomial 
disease spectrum -  other infections in this category would include nosocomial bacteraemias 
which are often associated with implanted medical devices. At the “common-but-treatable”
11
Chapter 1: Introduction
end of the spectrum are urinary tract infections (usually catheter-related), surgical site 
infections and diarrhoeal diseases. In between the two ends o f the spectrum are several “less- 
common-but-more-serious” diseases, including nosocomial tuberculosis infection, ventilator- 
associated and hospital-acquired pneumonias. Underpinning all o f these forms of disease is 
the issue o f antibiotic (or more strictly, antimicrobial) resistance -  this is often closely related 
to the nosocomial acquisition o f infection, especially for bacterial infections. Addressing 
whole the spectrum o f nosocomial infection research in developing countries as an entirety, 
the WHO Patient Safety group published a systematic review in 2011 (7), cataloguing the 
published studies in all the different fields and geographic areas that related to nosocomial 
infection -  see Figure 1-2.
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Chapter 1: Introduction
The results o f this literature review, especially the columns relating to studies 
conducted in Africa, illustrate the extremely limited extent o f research in this field in 
developing countries. Furthermore, much o f the limited existing research was found to be o f 
poor quality: according to the reviewers’ criteria, over half o f all studies included in the 
review were o f low overall quality and “health-care-associated infection was recorded 
poorly in some regions, particularly Africa and the western Pacific region. ” Additionally, 
“very few  articles reported antimicrobial resistance ”, although in the few articles that did 
address this topic, methicillin-resistant Staphylococcus aureus (MRSA) was frequently 
described. However, to some extent, this literature review may actually understate the amount 
o f research conducted in some fields o f nosocomial infection in developing countries - the 
review limited its scope to purely observational work. As we describe in Chapter 2 o f this 
thesis, there is actually a sizeable literature describing interventional studies for the 
prevention o f surgical site infection (SSI) conducted in sub-Saharan Africa -  although this is 
o f highly diverse methodological quality. Furthermore, by limiting the review period to 1995- 
2008, some relevant older work has been omitted. For example, in Chapter 5 of this thesis, 
we made comparison to a publication relating to hospital-acquired bacteraemia published in 
South Africa in 1992. Nonetheless, this review, and a subsequent publication by the same 
group focusing specifically on Africa (8) provide a comprehensive overview of HAI research 
-  or the lack thereof -  in developing countries. A commentary piece that accompanied the 
first review stated “Healthcare-associated infection in developing countries is a serious issue 
that is scarcely addressed in the scientific literature ”(9).
The history o f epidemiology o f hospital-acquired (or healthcare-associated) infection 
in Africa is limited -  very few researchers have tackled this issue, but on the basis o f the 
limited existing research, we would suspect that both the size o f the problem and also the 
scope for improvements might be considerable.
14
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1.2. Scope o f th is thesis
In the WHO reviews of this topic mentioned above, studies relating to SSI were the 
most commonly identified form of HA1 research undertaken in Africa. The authors in the first 
review noted “Surgical-site infection was the leading infection in hospitals, [...] strikingly 
higher than proportions recorded in developed countries”. The review of HAI research in 
African countries also emphasised the same finding. The major part o f this thesis relates to 
the epidemiology of SSI in an African context. The two other components of this thesis relate 
to nosocomial bacteraemia and MRS A transmission. Each of these three topics shares some 
common elements in the broader context of HAI in Africa, and in Figure 1-3 below I have 
outlined where these are covered in the thesis. This figure repeated at the start of each chapter 
to help the reader navigate the different subject areas of the thesis.
Figure 1-3: Them es of research
SSI Nosocomialbacteraemia MRSA
Previous research in sSA 
(or lack thereof)
Ch2 Ch 5 Ch 6
HAI surveillance methods in 
an African context
Ch 3 Ch 5 Ch 6
Antibiotic use and 
resistance in sSA
Ch 4 Ch 6
Impacts of HAI in sSA Ch 4 Ch 5
sSA = sub-Saharan Africa
In Chapter 2 o f this thesis, I performed a systematic review o f publications relating to 
interventions to prevent SSI in an African context, with the assistance of several surgical 
colleagues. We felt that it was useful to summarise this existing research in a way that made 
it easily accessible to the surgeon working in Africa, as much to illustrate the methodological 
pitfalls encountered in this kind of research as to summarise the actual results o f the studies. 
This review was published in March 2012.
Although several published studies have shown the frequent occurrence of SSI in 
African hospitals, I was not aware o f any studies that examined the methods associated with 
performing surveillance for this form of HAI in an African context. For the major work of 
this thesis, I introduced SSI surveillance at a single hospital in Kenya. This work was
15
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conducted in Thika Level 5 Hospital, in Central Province of Kenya, approximately 50km 
North-East of Nairobi -  see Figure 1-4. In Chapter 3 of this thesis, I examine some of these 
methods that were used in this surveillance in detail, focussing on consistency o f scoring of 
key parameters relating to SSI risk, use of a telephone-based post-discharge SSI surveillance 
method and performance of the CDC-NHNS Risk Index in major O+G surgery.
Figure 1-4: Location of two hospital study sites in Kenya
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In Chapter 4 , 1 describe the process of implementing a change in the use of antibiotic 
prophylaxis in Thika Hospital to bring this into line with national guidelines and the 
international evidence base. We used the same surveillance methods described in the 
previous chapter to assess the impact of this change in practice on the risk o f SSI and also 
consider the impact on resource utilization in the hospital.
In Chapter 5, I switch the focus to paediatric nosocomial bacteraemia and using a 
continuous 7-year period of inpatient surveillance data from Kilifi Hospital in Coast Province 
(see Figure 1-4 above), I describe some of the basic epidemiological and microbiological 
parameters relating to this form of HAI -  this was published in December 2011. This is
1 6
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followed by an appendix that accompanied publication of this report which gives further 
details about Kilifi Hospital, and then by a published correspondence that followed from the 
publication o f the original article.
In Chapter 6 ,1 describe an investigation into the occurrence o f MRS A carriage in 
adult inpatients in Thika Hospital, coupled with laboratory-based description of all the
S.aureus isolates obtained. Further laboratory investigations were performed at the University 
Medical Centre Groningen (UMCG), in the Netherlands. The original idea for this piece of 
work arose with the identification o f MRSA carriage in a small number o f inpatients in Thika 
Hospital. In the near-total absence o f other research into MRSA in East Africa, we believed 
that MRSA was more common than it ultimately turned out to be -  we originally envisaged 
collecting 50 MRSA isolates, but actually collected six MRSA and 80 Methicillin-sensitive S. 
aureus isolates. Although ultimately the conclusion was that MRSA carriage in Thika 
Hospital was quite rare, we still were able to make several original observations about this 
pathogen in this setting.
I conclude this thesis with a discussion in Chapter 7 o f the related strands o f work in 
healthcare epidemiology in Africa and outline what I believe are some of the important 
research, policy and practice issues for the future.
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A B S T R A C T
Background: There is a great need for safe surgical services in sub-Saharan Africa, but a major difficulty of 
performing surgery in this region is the high risk of post-operative surgical site infection (SSI).
Methods: We aimed to systematically review which interventions had been tested in sub-Saharan Africa 
to reduce the risk of SSI and to synthesize their findings. We searched Medline, Embase and Global 
Health databases for studies published betw een 1995 and 2010 w ithout language restrictions and 
extracted data from full-text articles.
Findings: We identified 24 relevant articles originating from nine countries in sub-Saharan Africa. The 
methodological quality of these publications was diverse, with inconsistency in definitions used for SSI, 
period and m ethod of post-operative follow-up and classification of wound contamination. Although it 
was difficult to synthesise information betw een studies, there was consistent evidence that use of 
single-dose pre-operative antibiotic prophylaxis could reduce, sometimes dramatically, the risk of SSI. 
Several studies indicated that alcohol-based handrubs could provide a low-cost alternative to  traditional 
surgical hand-washing methods. Other studies investigated the use of drains and variants of surgical 
technique. There were no African studies found relating to several other promising SSI prevention 
strategies, including use of checklists and SSI surveillance.
Conclusions: There is extremely limited research from sub-Saharan Africa on interventions to curb the 
occurrence of SSI. Although some of the existing studies are weak, several high-quality studies have been 
published in recent years. Standard methodological approaches to  this subject are needed.
© 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
1. Introduction
Performing surgery in sub-Saharan Africa has many challenges 
different from those encountered in high-income countries: costs 
are usually severely constrained: numbers of trained theatre staff 
are generally low and facilities are often rudimentary. However, one 
of the principal difficulties for the surgeon in sub-Saharan Africa is 
the high risk of post-operative surgical site infection (SSI). In two 
recent WHO-led review papers, the risk of SSI in developing coun­
tries was "strikingly higher than in equivalent surgical procedures in 
high-income countries"' and the problem was found to be particu­
larly acute in sub-Saharan Africa.2 Although extensive research into 
SSI prevention has been conducted in high-income countries, we
* Corresponding author. London School of Hygiene and Tropical Medicine. 
Keppel Street, London, UK.
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were aware of few interventional studies that had been conducted in 
sub-Saharan Africa. As SSI constitutes a major challenge for surgeons 
in African countries, we felt this might represent a significant 
“knowledge gap" in clinical science.
We therefore set out to summarise interventional studies 
conducted in sub-Saharan Africa that had attempted to reduce the 
risk of SSI. We systematically reviewed publications relating to this 
topic to collate the existing African research for the general surgical 
audience, and also outline the way forward for future studies 
addressing this important issue.
2. Methods
2.1. Search strategy
We aimed to identify all recent publications giving information on interventions 
used to reduce the risk of SSI where the research was conducted in countries in 
sub-Saharan Africa (sSA), without restriction to type of surgery or intervention.
1743-9191/$ -  see front matter © 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
d o i : 10 .10 1 6 / j. ijsu .2 0 1 2 .0 4 .0 0 4
AM. Aiken et al /  International Journal of Surgery 10 (2012) 242-249
We searched Medline, Embase and Global Health databases for reports published 
between January 1995 and December 2010 with no language restrictions. We used 
search terms as shown in Fig. 1.
Each title/abstract was screened by two of the authors and a decision on which 
full-text articles to retrieve was reached after discussion amongst all authors. 
Additional searches were performed using the reference sections of identified 
publications and the authors' own knowledge of the area. Articles were defined as 
■interventional" studies if the full-text manuscript contained information on at least 
two groups of patients for whom different management (of whatever type) had 
been used in an attempt to reduce the risk of SSI after any type of surgical procedure. 
"Interventional studies" were not limited to randomised controlled trials (RCT) -  
other direct comparisons (e.g. "before and after” studies) were also included.
22. Inclusion + exclusion criteria
We included interventional studies conducted in sSA published between 1995 
and 2010. We excluded studies where occurrence of SSI was not a major focus of the 
intervention. We excluded multicentre studies where data from African sites was 
not presented separately. We did not exclude any surgical specialities or reject any 
articles based on quality criteria.
3. Results
3.1. Search findings
Our search yielded 3105 abstracts, of which 247 were judged to 
be of possible relevance. From these 247, further abstracts were 
excluded as they contained purely descriptive data (i.e. no compar­
ison o f treatments/managements; n =  199) or microbiological 
reports of SSI in sSA (n = 19) (Fig. 2). Full-text articles were retrieved 
for 29 studies, of which seven made use of external comparison 
groups and therefore did not meet our definition of “interventional”. 
Two further studies were identified from additional searches. A total 
of 24 studies in English and French were included.
Studies originated from nine different countries, most 
frequently Nigeria (n =  8), followed by South Africa (n =  5), Cote 
d’Ivoire (n =  2), Kenya (n =  2), Tanzania (n =  2) and Uganda (n =  2). 
There was one study included from each of Ethiopia, Ghana and 
Mozambique. Studies were written in English (n =  22) and French 
(n =  2). For ease of presentation, w e separated the studies identified 
into those relating to the use of antibiotic prophylaxis (n =  10), pre­
operative interventions (n =  4), intra-operative interventions, 
including different surgical techniques and devices (n =  6) and 
post-operative interventions (n =  4) -  see Tables 1-4 , respectively, 
arranged by year of publication.
3.2. Comparison of studies: methodology
3.2.1. Study design
Patients undergoing a variety of surgical procedures formed 
the subjects for these studies: the majority of studies examined
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the effects of an intervention in a single type of surgery, most 
frequently Caesarean sections (n = l l) .  Most studies were con­
ducted in a single centre and used an individually randomised, 
controlled trial (RCT) design. One study used cluster 
randomisation (by operating theatre), two studies used a “before 
and after intervention” design and one study allowed surgeons 
to select their operating technique (relating to peritoneal 
closure) and passively observed results. Two studies of 
antibiotic prophylaxis used a placebo-control group, whilst all 
other studies used a recognised standard treatment as the control 
or baseline arm.
3.2.2. RCT components
There were marked variations in the key elements of RCT 
design and execution. Some studies clearly described the efforts 
made to achieve single blinding (investigator only) or double 
blinding (investigator and participant), although for some opera­
tive procedures, it would clearly be impossible to blind the 
surgeon to the treatment status. A well-conducted RCT of an 
antibiotic prophylaxis intervention in South Africa achieved 
double blinding by using a placebo solution with the same 
appearance as the antibiotic agent.3 The actual method used for 
randomisation was reported in 11% of RCTs (17/21), although two 
RCTs randomised by allocating alternate patients to the inter­
vention and control arms (alternating assignment).4'5 No RCTs 
were designed from the outset as therapeutic equivalence studies, 
but several studies finding no significant difference between 
intervention and standard treatments were interpreted by the 
authors as providing evidence of equivalence. Only one study6 
reported adherence to the CONSORT guidelines, which were first 
published in 1996.7
3.2.3. Study size
The total number of patients included ranged from 50 to 3317 
subjects, and most studies (17/24, 71%) did not include a sample 
size calculation.
3.2.4. SSI definitions
There was no consistent usage of any standard schema for 
defining or classifying surgical site infections. Eight studies 
provided their own definitions of what they judged to be an 
SSI, seven studies made reference to a schema described 
elsewhere and nine studies did not provide any (clear) definition 
of what they considered as an SSI. The most commonly 
referenced external schema for SSI classification was that of the 
Centres for Disease Control (CDC)5 -  this was referred to by 3 
studies.
Keywords MeSH terms
("surg*" OR "wound*") OR (surgery OR "wounds and injuries")
AND
, "infection*" OR "sepsis" \ 
' OR "handwash* '
OR (infection OR sepsis)
AND
. "sub-Saharan Africa" OR » 
' "name of any country in sSA" '
OR ("Africa South of the Sahara")
Fig. 1. Search items used for systematic review.
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Fig. 2. Flow diagram for selection of articles.
32.5. Follow-up
The post-operative follow-up period and the methods employed 
to achieve this were also highly variable. Follow-up periods used 
ranged from 5 days to 12 months. In most studies the follow-up 
period included both inpatient and outpatient periods (15/24, 
63*), though the intensity of effort in outpatient follow-up was 
diverse. Five studies only followed up patients until discharge and 
five studies did not report how follow-up was performed. In order 
to achieve high levels o f post-discharge follow-up, one study in 
Côte d’Ivoire reviewed patients on alternate days up to 30 days after 
their operation 8 and a study in Tanzania provided the transport 
fare and a free meal for participants who attended their 30-day 
post-operative review.9 A study in Kenya used telephone calls to 
contact patients after discharge,6 though no information was 
provided on the sensitivity or specificity of this method with 
respect to a gold standard of “in-person" physician or nurse review.
32.6. Wound contamination
Few studies (n = 4) made use of a schema for stratifying patients 
by degree of wound contamination, such as the Surgical Wound 
Class,10 though some studies stated that they excluded patients 
with unusually contaminated surgical wounds.
3.3. Comparison o f studies: effects o f interventions
It is challenging to summarise the effects o f these different 
interventions due to the variation in SSI definitions, follow-up 
periods and methods between studies and the failure of most 
studies to describe the extent of wound contamination.
3.3.1. Antibiotic prophylaxis (Table 1)
The most commonly examined intervention for preventing SSI 
was the use of antibiotic prophylaxis (n =  10), either in comparison 
to a placebo treatment, or more normally in comparison to an 
alternative prophylaxis regime. Many different drug regimes were 
examined, in the context o f a variety of different surgical proce­
dures. Precise information about actual timing of dose adminis­
tration and re-dosing during long procedures was only given in 
2/10 studies. Several studies compared the use of a single-dose pre­
operative intravenous administration regime against a “standard" 
regime of prolonged post-operative antibiotic prophylaxis. All of 
these studies found that a single-dose pre-operative dosing regime 
was superior to a prolonged post-operative regime, either in terms 
of reduced use of drugs911 ~15 or reduced risk of SSI.916 One study in 
Tanzania showed a pronounced effect of implementation of 
a single-dose pre-operative amoxillin/clavulanate prophylaxis 
regime: the risk of SSI declined from 21.6* to 4*.9 Studies where the 
use of post-operative antibiotic prophylaxis was avoided or 
restricted reported no adverse effects of such a restriction. Both the 
placebo-controlled trials, including one study of cefoxitin prophy­
laxis for C-section patients in South Africa,3 found no benefit of use 
of antibiotic prophylaxis over placebo.
3.3.2. Pre-operative interventions (Table 2)
Amongst the (non-antibiotic) pre-operative interventions 
(n =  4), two studies on the use of an alcohol-based handrub as an 
alternative to the traditional surgical hand-washing agents gave 
consistent results. A large cluster-randomised trial conducted in 
Kenya6 showed no significant difference in the risk of SSI when an 
alcohol-based handrub was substituted for the traditional 
soap + water used for the pre-operative surgeon’s hand-wash. 
Costs for the alcohol handrub were found to be similar to tradi­
tional hand-washing method, and the authors noted that alcohol 
handrub might be much more convenient for institutions where 
water supply was erratic. A “before and after” study in Cote 
d'Ivoire8 provided similar results and judged that alcohol handrub 
would be much more cost-effective for an institution to provide. A 
study in Nigeria17 examined the use of a locally produced soap - 
+ methylated spirit preparation for use in cleaning the patient's 
skin pre-operatively, in comparison to (much more expensive) 
povidone-iodine — no difference in the risk of SSI was detected. No 
studies examined the use of pre-operative checklists as a tool for 
making surgery safer.
3.3.3. Intra-operative interventions (Table 3)
Studies relating to intra-operative interventions (n = 6) mainly 
related to different operative techniques. Four studies5,18-20 
examined two alternative surgical techniques that might reduce
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the operating time in Caesarean sections (peritoneal non-closure 
and the Misgav-Ladach incision) -  all studies reported shorter 
duration of surgery without elevated SSI risk in the experimental 
arm of the study with elevated SSI risk. One study in Uganda21 
compared the use of two different ventriculo-peritoneal (VP) 
shunts -  one system was almost 20 times cheaper than the other 
with an equivalent risk of shunt complications including blockage, 
device infection and SSI. One study in South Africa22 described an 
experimental technique for circumcision of adults (Tara-Klamp) -  
this was found to have many drawbacks, including higher risk of SSI.
3.3.4. Post-operative interventions (Table 4)
Amongst studies examining post-operative interventions to 
reduce the risk of SSI (n 4), three studies examined the use of 
wound drains in the post-operative period23 25 -  we considered 
these as a "post-operative” intervention, although drains were 
inserted intra-operatively. None of these studies found a benefit in 
terms of reduced risk of post-operative complication with more 
extensive use of drains, and one study found higher risk of SSI in 
patients with drains (for thyroid surgery). There appears to be 
consistent evidence that the use of post-operative wound drains 
should be as conservative as possible in an African surgical setting. 
No studies on post-operative SSI surveillance as a method of 
reducing SSI risk at the institutional level were found.
4. Discussion
Over a 15-year review period, we found only 24 studies 
describing interventional studies conducted in sub-Saharan Africa 
for reducing the risk of post-operative SSI, although ten of these 
were from the last three years of the review period (2008-2010).
4.1. Limitations of studies
There were many common errors in designing interventional 
research studies relating to SSI in Africa. For example, two studies 
used alternating assignment to “randomise” patients — this is not 
a suitable method as it allows easy prediction of which treatment 
the patient will receive. Many studies were likely to be too small to 
properly evaluate the effect of their intervention on the primary 
outcome (under-powered) -  this could have addressed by per­
forming proper sample size calculations or by combining studies 
across several sites. However, larger trials are more expensive and 
multicentre studies present their own logistical challenges. A 
common misunderstanding in trial interpretation was that failure 
to find a difference does not mean proof of equivalence -  special 
trial designs (non-inferiority or equivalence trials) are needed to 
prove equivalence.
The lack of consistency of SSI definitions, follow-up methods 
and time-periods makes comparisons between these existing 
studies difficult. Few studies used comparable definitions of what 
was considered as an SSI and how these were detected. The degree 
of contamination of the surgical wound is known to be an 
extremely strong predictor of the risk of SSI in low-income 
settings,1 so use of such a standard stratification system would 
have facilitated comparisons of the effect of interventions.
4.2. Potential future improvements
Some solutions to these problems that could be applied in the 
future are as follows: adoption of the standard definitions and 
classification of SSI as provided by the CDC26 and of the Surgical 
Wound Class as used in various studies.10 The CDC defines SSI as an 
infection at the site of the operation within 30 days of the proce­
dure or within 12 months if there is implanted material -  universal
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adherence to this follow-up period would facilitate comparison 
between studies. In low-resource settings in sSA, it may be difficult 
to achieve post-operative follow-up when travelling to clinic 
appointments is prohibitively expensive for patients. Some inno­
vative approaches to post-discharge follow-up (such as contacting 
patients by telephone) identified in this review may be suitable for 
further examination in an African context — these need further 
examination of their sensitivity and specificity in detecting SSI in 
this context.
4.3. Research findings
The existing African research on SSI prevention does provide 
some important messages which need wide dissemination. Correct 
use of surgical antibiotic prophylaxis (i.e. single dose, pre-operative 
delivery) can, in some circumstances, lead to very dramatic 
reductions in the risk of SSI and can also reduce costs for the patient 
or institution. This goes directly against the widely held belief 
amongst African surgeons [in our experience] that “poor hygiene" 
or crowding in their wards necessitates prolonged post-operative 
antibiotic usage. Two studies showing no benefit of pre-operative 
antibiotic prophylaxis over placebo serve to remind prophylaxis 
regimes are not universally efficacious -  locally appropriate agents 
must be determined. Improved use of antibiotic prophylaxis across 
sub-Saharan Africa could cut the risk of SSI and simultaneously 
conserve precious (antibiotic) resources. Use of alcohol handrubs 
has been shown in two studies to be equivalent (in terms of SSI risk) 
to traditional soap + water for pre-operative hand-washing by the 
surgeon and may lead to cost-savings for the institution -  this low- 
cost technology deserves further evaluation across the continent. 
Use of post-operative drains should be sparing and early discharge 
should be encouraged, where possible. Some variations in surgical 
technique were found to be promising, but need more extensive 
evaluation of their acceptability to surgeons and patients. Some 
“low-cost” alternative surgical implants and consumables appeared 
to be equivalent to the standard versions.
Many of these findings are consistent with research and 
guidelines for preventing SSI originating from high-income 
settings.27-31 No research studies examining the use of checklists 
or post-operative SSI surveillance were identified -  these are 
promising areas for future work.
5. Conclusions
Although little research on how to prevent SSI in surgical 
practice in sub-Saharan Africa has been published, there are some 
encouraging signs -  several high-quality studies have been 
undertaken in recent years and promising new methodologies and 
technologies are apparent. This review highlights the inconsistency 
of SSI definitions and follow-up methods that have been used in 
studies in sub-Saharan Africa in the past, and suggests that these 
could be resolved in the future by use of standard international 
definitions o f SSI, such as those provided by the CDC. Important 
lessons can be drawn from the existing research -  proper use of 
antibiotic prophylaxis in surgery can dramatically reduce the risk of 
SSI and alcohol-based preparations may provide a low-cost alter­
native to traditional surgical hand-washing and skin preparation 
methods.
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Background: In low-income countries, surgical site infections (SSIs) are a very frequent 
form of hospital-acquired infection. Surveillance is an important method for controlling SSI 
but it is unclear how this can best be performed in low-income settings.
Aim: To examine the epidemiological characteristics of various components of an SSI 
surveillance programme in a single Kenyan hospital.
Methods: The study assessed the inter-observer consistency of the surgical wound class 
(SWC) and American Society of Anesthesiologists (ASA) scores using the kappa statistic. 
Post-discharge telephone calls were evaluated against an outpatient clinician review 'gold 
standard’. The predictive value of components of the Centers for Disease Control and 
Prevention — National Healthcare Safety Network (CDC-NHNS) risk index was examined in 
patients having major obstetric or gynaecological surgery (OEtG) between August 2010 and 
February 2011.
Findings: After appropriate training, surgeons and anaesthetists were found to be 
consistent in their use of the SWC and ASA scores respectively. Telephone calls were found 
to have a sensitivity of 70% [95% confidence interval (Cl): 47-87] and a specificity of 100% 
(95% Cl: 95—100) for detection of post-discharge SSI in this setting. In 954 patients 
undergoing major OEtG operations, the SWC score was the only parameter in the CDC-NHNS 
risk index model associated with the risk of SSI (odds ratio: 4.00; 95% Cl: 1.21-13.2; 
P =  0.02).
Conclusions: Surveillance for SSI can be conducted in a low-income hospital setting, 
although dedicated staff, intensive training and local modifications to surveillance 
methods are necessary. Surveillance for post-discharge SSI using telephone calls is 
imperfect but provides a practical alternative to clinic-based diagnosis. The SWC score 
was the only predictor of SSI risk in O&G surgery in this context.
© 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
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Introduction
A World Health Organization (WHO) systematic review in 
2011 on hospital-acquired infections (HAIs) highlighted the 
scarcity of studies from low-income countries and from African 
countries in particular.1 From limited information, surgical site 
infections (SSIs) were identified as a significant problem: the 
risk in developing countries was 'strikingly higher than in 
equivalent surgical procedures in high income countries’.
Conducting surveillance for SSIs is recognized as making an 
important contribution to reducing the risk of these infections. 
Establishing high-quality surveillance with timely feedback to 
surgeons can lead to reduction in risk of SSI.2 A systematic 
review of interventions for preventing SSI in sub-Saharan Africa 
found no examples of surveillance being conducted with the 
primary purpose of reducing the risk of SSI.3
The SENIC project (Study on the Efficacy of Nosocomial 
Infection Control) had demonstrated that the critical compo­
nents of SSI surveillance were: (i) accurate collection and 
reporting of information; (ii) appropriate stratification of risk.4 
For the first component, methods for accurate collection of 
information for SSI surveillance have been extensively 
researched in high-income countries.5,6 However, these 
methods are not applicable in hospitals in low-income settings 
where data extraction from inpatient records is challenging 
and electronic linkage to primary healthcare records is 
impossible. In all settings, many SSI cases occur after discharge 
from hospital.6 Incorporating these cases into surveillance 
systems is especially problematic in low-income settings, 
where surgical patients are often dispersed over a wide area.
For the second component of SSI surveillance, an appro­
priate system of risk stratification is needed to make compar­
isons of the risk of SSI between centres or over time. The 
Centers for Disease Control and Prevention -  National 
Healthcare Safety Network (CDC-NHSN) risk index provides one 
such system. A score of 0 -3  is assigned based on the sum of 
values derived from the American Society of Anesthesiologists 
physical status classification (ASA) score, the surgical wound 
class (SWC) and operation duration in relation to a procedure- 
specific length (time Tj.7 Although these components of the 
risk index are, in principle, readily transferable to low-income 
settings, an important question is whether accuracy of scoring 
in routine clinical practice in such settings is adequate to 
reliably predict risk of SSI.
The aim was to evaluate epidemiological characteristics of 
various components of SSI surveillance in a low-income hospital 
setting in sub-Saharan Africa. We evaluated: the inter-observer 
consistency of SWC and ASA scoring; the sensitivity and speci­
ficity of telephone calls for identifying SSI against a clinician 
review 'gold standard’; the association of CDC-NHSN risk index 
components with the risk of SSI in this setting.
Methods
Thika Level 5 Hospital is a 300-bed government hospital in 
the town of Thika, about 50 km north east of Nairobi, in Central 
Province of Kenya. At Thika Hospital there are six consultant 
surgeons and a rotating pool of 16-20 medical ofñcers (junior 
doctors) and clinical officers (vocationally trained clinicians) 
who carry out a range of elective and emergency surgical 
procedures. There are four operating theatres and about 300
major and minor operations take place monthly. Caesarean 
sections are the most commonly performed procedure. Surgical 
instruments are reprocessed in a steam autoclave with moni­
toring by a change in colour of sealant tape. Prior to February 
2011, antibiotic prophylaxis was normally administered to 
patients postoperatively, as is standard practice in many 
government hospitals in the region. Thika Hospital is not 
a university hospital, nor does it have an extensive history of 
research collaborations. It is a typical mid-sized Kenyan 
government hospital.
As a collaborative project between the Ministry of Medical 
Services, the Kenya Medical Research Institute and Thika 
Hospital, SSI surveillance was conducted at Thika Hospital for 
a continuous period from August 2010 to December 2011.
All patients gave written consent to participation in 
surveillance, which included contact by phone after discharge 
from hospital. This study was approved by the KEMRI National 
Ethical Review Committee.
Postoperative patient reviews, data and sample collection, 
phone calls and data entry were performed daily by a team of 
hospital staff members (two clinical officers and four support 
staff). All data for CDC-NHNS risk index criteria were recorded 
by hospital surgeons and anaesthetists. We diagnosed SSI in 
accordance with CDC-NHSN definitions as far as possible given 
the diagnostic facilities available.8 Microbiological criteria 
were not used for SSI diagnosis, although microbiology services 
at Thika Hospital were upgraded as part of the surveillance. All 
diagnoses of SSI were discussed with the relevant surgical team 
and an infectious diseases physician. Feedback of ongoing 
surveillance results was given in writing and discussed in 
a series of multidisciplinary seminars.
In our surveillance, we included all surgical operations 
where a surgical wound was created during the procedure and 
the patient stayed overnight in hospital. We therefore 
excluded patients having day-case surgery (including all ear/ 
nose/throat, ophthalmic and minor gynaecological procedures) 
and debridement of traumatic or infected wounds. During their 
inpatient stay, postoperative patients were reviewed at every 
dressing change, normally starting on the third postoperative 
day and on alternate days thereafter. Patients remained in SSI 
surveillance for 30 days after all eligible surgical operations, 
including both inpatient and outpatient periods. Postoperative 
réadmissions to Thika Hospital were actively sought daily. After 
discharge, telephone-based surveillance was conducted as 
described below. Patients were encouraged to contact the 
surveillance team if they received treatment for wound 
complications at another facility.
All information for SSI surveillance was recorded in 
a custom-made PHP-MySQL database. Statistical analyses were 
performed using Stata v12 software (Stata Corp., College 
Station, TX, USA).
Consistency of SWC and ASA scores
Scoring consistency tests were conducted with the Surgery, 
Obstetrics and Gynaecology (0&G) and Anaesthetics depart­
ments in Thika Hospital. In each department, a series of 10 case 
histories was developed describing patient scenarios similar to 
those encountered in local practice. After revision of the 
relevant scoring system, all departmental members indepen­
dently scored the SWC or ASA for these case histories. These 
results were presented to each department and the need to
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ensure inter-observer consistency was explained. Various 
different approaches to improving consistency were employed: 
departmental discussions, educational meetings and written 
guidelines and posters in departments. Among surgeons, 
a second round of this exercise was conducted with actual 
patients; in the 06G and Anaesthetics departments, a second 
round of this exercise used different paper-based case 
histories.
As the scoring depended on making a clinical judgement, no 
answer was considered 'correct’: the kappa statistic (k) was 
employed to assess inter-observer consistency. A weighted k 
was used to account for the ordered nature of the scoring 
categories.
Sensitivity and specificity of telephone-based 
surveillance
conducted between August 2010 and February 2011. Time T 
represented 1 h for all of these procedures. We did not include 
other procedures in this modelling as the risk index is only 
intended to be applied to groups of similar procedures -  there 
were insufficient numbers of any other operative group for 
adequate evaluation.
Results
Following extensive development, training and piloting, SSI 
surveillance was conducted at Thika Hospital for a 16-month 
continuous period from August 2010 to December 2011). All 
consecutive adult and paediatric patients undergoing eligible 
operative procedures were enrolled.
At discharge, patients (or their guardians) were asked to 
give a mobile phone number where they could be contacted 
during the next 30 days. More than 90% of patients provided 
this. Patients were contacted twice by mobile phone on 
approximately the 14th and 28th postoperative days to inquire 
about wound complications since discharge. Surveillance staff 
asked a standard series of questions regarding current condi­
tion of the wound, and distinguished between presence of 
(normal) postoperative mild pain, itching and serous ooze and 
(abnormal) severe pain, wound breakdown and purulent 
discharge. Patients could also contact the SSI surveillance team 
by phone. Patients reporting current symptoms consistent with 
wound infection were asked to re-attend Thika Hospital for 
free outpatient review.
Using clinician review in the outpatient clinic as the diag­
nostic gold standard, paired observations of telephone inter­
view and direct clinician review were analysed when these 
were performed within 48 h of each other to determine the 
sensitivity and specificity of telephone calls as a diagnostic 
test. It was assumed that 'wound infection status’ could not 
change within a 48 h period.
Consistency of SWC and ASA scores
Consistency studies were conducted for the SWC and ASA 
score as shown in Table I. Junior staff rotated between 
departments every three months, so this exercise could not be 
repeated in the surgical departments at intervals longer than 
this. The second exercise was performed in the Anaesthetics 
department after a 13-month interval.
Whereas consistency of scoring between clinicians initially 
ranged from fair (within the O&G department) to excellent 
(within the Surgery department), after a period of routine use 
of these scoring systems, the consistency between clinicians 
improved in all departments. The high degree of consistency 
achieved in the Surgery department in a ’paper-based’ exercise 
(k =  0.81) was replicated when the same approach was applied 
with actual patients (ic =  0.83, based on 55 paired observa­
tions). Subsequently, continuous training of incoming staff was 
used to maintain these high levels of consistency.
Validity of telephone-based surveillance
Performance of CDC-NHSN risk index
To analyse the predictive performance of the CDC-NHNS risk 
index, all forms of SSI were re-categorized (including those 
occurring after discharge) into a single outcome variable. 
Exposure variable data were extracted from medical notes at 
the time of the operation. Logistic regression was used to 
analyse risk index components in a group consisting of 
caesarean sections and major gynaecological operations
___ - - -. wuipducin. cunician r6Visws
and telephone interviews within 48 h of each other. For 23
patients diagnosed in outpatients by a clinician as having SSI, 
16 of these had been judged to have SSI in their telephone 
interview. For 66 patients seen in outpatients by a clinician and 
considered not to have SSI, none of these had been considered 
to have SSI in their telephone interview. On the basis of these 
results, the sensitivity of telephone calls was 69.6% [95% 
confidence interval (Cl): 47.1-86.8%] and the specificity was 
100% (95% Cl: 95-100%).
Table I
Results of scoring consistency projects
No.
of staff
Department Test First exercise
Anaesthetics 
oaG 
Surgery
ASA
SWC
SWC
Date_____ Average weighted k score Date
Jun 2010 
Jun 2010 
Jun 2010
ASA, American Society of Anesthesiologists: SWC, surgical wound class.
There are no P-values associated with ic as it does not test a particular hypothesis.
* All exercises compared paper-based scenarios except the second exercise in surgery which examined actual Datients 
b Only four of the five participants undertook the second exercise. y
Second exercise*
Average weighted k score
Ö89 
0.72 
0.83
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Description of surveillance operations and 
performance of CDC-NHSN risk index
Between August 2010 and February 2011, a total of 1172 
operations conducted at Thika Hospital were followed up in SSI 
surveillance. The characteristics of these operations are given 
in Table II. As caesarean sections predominated among these 
procedures (75% of operations), surveillance mainly included 
women of child-bearing age. A wide variety of other operations 
were also included in surveillance including laparotomies, 
hysterectomies, hernia repairs, appendicectomies and ampu­
tations. There was a high risk of SSI in orthopaedics and 
neurosurgery (14%), reflecting the high incidence of exten­
sively contaminated road-accident trauma in this hospital. 
Surgery performed by clinical officers (vocationally trained 
clinicians) did appear to have elevated risk of SSI (15%) 
although this is based on a very small number of procedures. 
Antibiotic prophylaxis was normally delivered as a post­
operative regime, as is widely used in hospitals in Kenya, We 
have not calculated an overall risk of SSI in the surveillance
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cohort -  this is strongly dependent on the mix of procedures, 
which is outside of institutional control.
The performance of the CDC-NHSN risk index in predicting 
the outcome of SSI (of any type, including post-discharge 
infections) in caesarean sections and major gynaecological 
operations is given in Table III. For individual components of 
the risk index, only the parameter derived from the SWC (odds 
ratio: 3.93; 95% Cl: 1.25-12.4; P  =  0.02) was significantly 
associated with the risk of SSI -  this remained the case in 
a multivariate model. Parameters relating to the ASA score and 
the duration of the operation were not associated with the risk 
of SSI in these operations.
Discussion
There are very few previous reports that have studied SSI 
surveillance methods in sub-Saharan Africa, and we are 
unaware of any that have examined either the consistency of 
scoring of risk index components or the characteristics of 
telephone calls as a surveillance method for SSI.9,10 This study
represents the largest SSI surveillance cohort reported in sub- 
Saharan Africa.
Table II
Risk of surgical site infection (SSI) in operations at Thika Hospital, 
Kenya: August 2010-February 2011
Variable Total no. SSI events (% of all)
Patient age (years)
<14 32 0(0)
15-39 1015 76 (7.5)
40-65 110 16 (14.6)
>65 15 1 (6.7)
Patient sex
Female 1060 82 (7.7)
Male 112 11 (9.8)
Type of surgery*
Caesarean section 882 64 (7.3)
General surgery 144 12 (8.3)
Orthopaedic/neurosurgery 36 5 (13.9)
Gynaecological 110 12 (10.9)
Surgeon grade
Consultant 198 17(8.6)
Medical officer 685 51 (7.5)
Medical officer intern 266 21 (7.9)
Registered clinical officer 20 3(15.0)
Preoperative antibiotic prophylaxis“
Given 18 2(11.1)
Not given 1154 91 (7.9)
Postoperative antibiotic prophylaxis/treatment0
Given 1169 91 (7.8)
Not given 3 1 (33.3)
Total operations followed up 1172 93 (7.9)
* Includes caesarean section with tubal ligation (N =  36) and with 
hysterectomy (4); general surgery includes laparotomy (61), hernia 
repair (19), appendicectomy (10); orthopaedic/neurosurgery 
includes open reduction internal fixations (9), limb amputations (7) 
and plating procedures (5); gynaecological surgery includes hyster­
ectomy (43), salpingectomy (11), cystectomy (8).
“ Antibiotics administered in the 60 min before the start of 
surgery.
c Any antibiotic prescription written up to  start/continue imme­
diately after surgery.
After appropriate training and with ongoing feedback, 
surgeons and anaesthetists in Thika Hospital were consistent in 
categorization of SWC and ASA scores in paper-based evalua­
tions. This consistency improved over time and was similar 
when applied to actual patients. On this basis, the scoring of 
these indices by clinicians in this setting can achieve an 
adequate consistency to make them suitable for use as SSI risk 
stratification variables.
The sensitivity and specificity of telephone calls as a post­
discharge follow-up tool for SSI surveillance were 70% and 
100% respectively. Although this was based on a relatively small 
number of paired observations, the analysis was restricted to 
those observations within 48 h of each other to maximize 
accuracy. Specificity was high as there were no false-positive 
telephone-based diagnoses (type 1 errors) among our paired 
observations. The moderate sensitivity obtained means that 
some genuine SSI cases may have been missed (type 2 errors) in 
surveillance. This combination of high specificity and moderate 
sensitivity are satisfactory characteristics for a ’stand-alone’ 
test where the outcome is rare. During the pilot phase of 
surveillance, we had found that in Thika Hospital the actual 
attendance at postoperative outpatient appointments was 
extremely poor (<25%). Researchers in Tanzania had also found 
poor attendance (54%) at postoperative follow-up appoint­
ments.9 Telephone calls have also been used for post-discharge 
SSI detection in a cluster-randomized trial of a surgical hand­
washing intervention in Kenya, although that study did not 
examine the sensitivity or specificity of the method.11 Tele­
phone calls appear to be a reasonable method of detecting 
post-discharge SSI in this setting, although this should be 
further evaluated as a diagnostic tool.12 This method may be 
population-specific as Kenya has very high penetration of 
mobile phone services.
Surgical wound class was predictive of risk of SSI in the 
univariate and multivariate models in major O&G operations. 
This is consistent with studies from Tanzania and Ethiopia and 
with findings from elsewhere in the world, where SWC remains 
a cornerstone of SSI risk stratification.1,8,10,13
Few studies in Africa have examined the use of the ASA score 
as a predictor of SSI risk. The ASA score approximates ’global’
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Table III
CDC-NHSN risk index in Thika Hospital, Kenya in major Obstetrics and Gynaecology surgery* (N =  954)
Variable Total no. SSI (any) Individual component Full risk index
OR (95% Cl) P-value OR (95% Cl) P-value
Surgical wound class
Clean 103 9
Clean-contaminated 834 59
Contaminated 13 2
Dirty-infected 4 2
CDC-NHSN categorization
Clean or clean-contaminated 937 68 1.0 —
Contaminated or dirty-infected 17 4 3.93 (1 .25-12.4) 0.02 4.00 (1.21-13.2) 0.02
ASA score
ASA 1 629 44
ASA 2 294 25
ASA 3 27 3
ASA 4 - 5 4 0
CDC-NHSN categorization
ASA 1 -2 923 69 1.0 —
ASA 3 -5 31 3 1.32 (0.39-4.47) 0.65 0.88 (0.24-3.22) 0.85
Operation duration (min)
<30 162 9
30 -6 0 616 46
60-120 171 16
>120 5 1
CDC-NHSN categorization
<60 min 778 55 1.0 —
>60 min 176 17 1.41 (0.79-2.49) 0.24 1.25 (0.77-2.04) 0.37
Total operations 954 72
CDC-NHSN, Centers for Disease Control and Prevention -  National Healthcare Safety Network; SSI, surgical site infection- OR odds ratio- Cl 
confidence interval; ASA, American Society of Anesthesiologists. ’ ' d s rat
* Includes all types of caesarean section, hysterectomy, salpingectomy, cystectomy and oophorectomy.
patient health at the time of the operation, and is a reliable 
predictor of the risk of SSI in high-income settings.14 However, 
it provided no useful predictive information in this setting 
when applied to major oaG  operations. This may be because 
these procedures were mainly performed on healthy young 
women among whom higher scores were rarely assigned, which 
may limit the utility of the ASA score as a discriminator of risk. 
In other African studies, the ASA score was strongly predictive 
of risk in a mixture of obstetric and general surgical procedures 
in Tanzania but only weakly predictive of risk in a study of 
paediatric surgery in Nigeria.10,15
The duration of an operation gives an indication of the 
complexity of performing that specific procedure. When this is 
compared to a standard length, this can predict the risk of 
subsequent complications. Operation duration was predictive 
of SSI risk in several studies in low-income settings, though 
using 'local' values for standard operation length was found to 
improve the predictive power.9,10,16,17 The duration of surgery 
in this study was not associated with the risk of SSI in major 
OEtG operations.
There are limitations to our study. Both the evaluation of 
the consistency of SWC and ASA scores and the sensitivity and 
specificity of telephone calls are based on relatively small 
numbers of observations. However, these are the most detailed 
examinations of these topics in the region to date. The evalu­
ation of the CDC-NHNS risk index in O&G surgery is the largest 
such group ever reported in sub-Saharan Africa.
Six full-time staff with salaries equivalent to entry-level 
nurses were required to conduct this surveillance. About 250 
procedures were followed up each month. The high cost of 
supporting these staff meant that surveillance could not be 
sustained beyond the duration of this collaborative project. 
Commercially available software for SSI surveillance might 
have been a cheaper alternative to our bespoke, locally pro­
grammed database.
The value of surveillance is providing surgeons with 
comparative data about their specific performance. Combining 
many different types of procedure with different intrinsic risks 
of infection is therefore of no real value. In the smaller 
throughput types of surgery, it would be necessary to collect 
surveillance data for much longer periods or across many sites 
in order to adequately evaluate the risks of SSI.
In conclusion, surveillance is an important method of 
measuring and controlling SSIs, which are recognized to 
be a significant form of HAI in sub-Saharan Africa. In a low- 
income hospital setting it was found that surgeons and 
anaesthetists can assign consistent scores for the SWC and 
ASA; ongoing training and feedback are required. Telephone 
calls appear to be a reasonable method of detecting post­
discharge SSI cases, although further evaluation is needed. 
Of the components of the CDC-NHNS risk index, only the 
SWC provided useful predictive information on the risk of SSI 
in our hospital, where caesarean sections represent the bulk 
of operations.
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Abstract
Background
In low-income countries, Surgical Site Infection (SSI) is a common form o f hospital-acquired 
infection. Antibiotic prophylaxis is an effective method o f preventing these infections, if  
given immediately before the start o f  surgery. Although several studies in Africa have 
compared pre-operative versus post-operative prophylaxis, there are no studies describing the 
implementation o f policies to improve prescribing o f surgical antibiotic prophylaxis in 
African hospitals.
Methods
We conducted SSI surveillance at a typical Government hospital in Kenya over a 16 month 
period between August 2010 and December 2011, using standard definitions o f  SSI and the 
extent o f contamination o f surgical wounds. As an intervention, we developed a hospital 
policy that advised pre-operative antibiotic prophylaxis and discouraged extended post­
operative antibiotics use. We measured process, outcome and balancing effects o f this 
intervention in using an interrupted time series design.
Outcome
Following introduction o f the policy in February 2011, there was rapid adoption o f the use of 
pre-operative antibiotic prophylaxis and a substantial immediate decrease in the use o f post­
operative antibiotics in Clean and Clean-Contaminated surgery which also declined over time 
thereafter. There was no immediate step-change in risk o f SSI, but overall, there appeared to 
be a moderate reduction in the risk o f superficial SSI across all levels o f wound 
contamination. There were marked reductions in the costs associated with antibiotic use, the 
number o f intravenous injections performed and nursing time spent administering these.
Lessons learned
Implementation of a locally developed policy regarding surgical antibiotic prophylaxis is an 
achievable quality improvement target for hospitals in low-income countries, and can lead to 
substantial benefits for individual patients and the institution.
Keywords: surgical site infection; antibiotic prophylaxis; antibiotic stewardship; quality 
improvement; Kenya.
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This paper is written specifically to meet the requirements o f the Health in Action format of 
the journal PLoS Medicine. The following are descriptions o f this format, from various 
different sources:
"The Health in Action section focuses on innovative health im provem ent projects. These 
pieces are often written by health activists, non-governm ental organizations, or  
researchers in low  incom e settings. We are particularly interested in featuring articles by 
groups or individuals w ho rarely have a voice in medical journals.
The piece should  be up to 2500 words, with up to 20  references and 2-3 display items. We 
ask authors to first set the scene (w hy  was y o u r  project needed?), then describe the project 
itself and discuss any early results o f  the project and the barriers and  difficulties y o u  have 
faced. Finally, we ask authors to end by looking to the future: where is the project heading 
next?"
"Health in Action articles focus more on implementation and lessons learned than straight reporting of a 
study. If you are interested to revise and submit your article in this format, you would need to resubmit 
the full article as a new submission and make sure that you choose Health in Action as the article type."
"A Health in Action article is restricted to 2500 words with up to 3 graphics (tables, figures, box). You will 
need to revise your article so that it no longer follows the Introduction, Methods, Results, and Discussion 
(IMRaD) format and instead focus on the lessons and messages for others who wish to implement a 
similar protocol.”
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Background
A World Health Organisation (WHO) systematic review in 2011 on hospital-acquired 
infections (HAI) highlighted the scarcity o f  studies from developing countries (1). On the 
basis o f limited information, Surgical Site Infections (SSIs) were identified as a particular 
problem: the risk in developing countries was “strikingly higher than in equivalent surgical 
procedures in high income countries’\  A further WHO review confirmed the extremely high 
risk o f  SSI in African surgical patients (2).
Antibiotic prophylaxis in surgical patients is an effective means of reducing the risk o f  post­
operative SSI (3) and a recent systematic review found that research studies conducted in 
sub-Saharan Africa supported this finding (4). The most effective dosing for antibiotic 
prophylaxis is achieved by giving a single intravenous injection approximately 30 minutes 
before the start o f the procedure (5), though the WHO Safe Surgery checklist indicates that it 
is acceptable to give prophylaxis between 0 and 60 minutes pre-operatively. There is no 
evidence to support the use o f post-operative antibiotics in a prophylactic role: scientific 
opinion has reached the consensus that these confer no benefit and should be avoided (6). 
Nonetheless, many surgeons in both high- and low-income settings continue to use antibiotics 
in this way: such prescribing increases costs and contributes to the selective pressure driving 
antibiotic resistance.
Achieving measureable and sustained improvements in the quality o f healthcare is 
challenging in any setting, but in low-income countries examples o f effectively introducing 
evidence-based practices are scanty (7). Although the emergence o f antimicrobial resistance 
could reverse much o f the health gains achieved in Africa in the last half century (8, 9), there 
is a dearth o f reports from African countries o f antibiotic stewardship interventions: a 2009 
Cochrane Review o f interventions to improve antibiotic prescribing for hospital inpatients 
found no reports from African countries (10).
We report our experience o f developing and implementing a Surgical Antibiotic Prophylaxis 
(AP) policy as an intervention to change healthcare practitioners’ prescribing behaviour in a 
single Government hospital in Kenya. We prospectively measured the effects o f this 
intervention in terms o f process, outcome and balancing measures.
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Setting and Methods
Thika Level 5 Hospital is a 300-bed Government Hospital in the town o f Thika, 
approximately 50km NE o f Nairobi, in Central Province o f Kenya. It has six consultant 
surgeons and a rotating pool o f 16-20 junior doctors and clinical officers (clinically-trained 
healthcare professionals) who carry out approximately 300 elective and emergency 
operations monthly. As a collaborative project between the Ministry o f Medical Services, the 
Kenya Medical Research Institute and Thika Hospital, we conducted SSI surveillance at 
Thika Hospital from August 2010 to December 2011 for all patients undergoing surgical 
procedures involving overnight admission to Thika Hospital. Patients remained in SSI 
surveillance for 30 days after all operations, encompassing both inpatient and outpatient 
periods. Information regarding patients, operations, prescribed and administered drugs were 
extracted from patient medical records within 24 hours of recording. After discharge from 
hospital, we contacted patients by phone to determine the occurrence o f post-discharge SSI. 
Further examination o f these methodological approaches used for this SSI surveillance is 
described elsewhere (11).
Surveillance activities were performed daily by a team o f hospital staff members (2 clinical 
officers and 4 support workers) throughout the period with on-site supervision by a clinical 
epidemiologist. Surgical wound class (Clean, Clean-Contaminated, Contaminated, Dirty) was 
assigned by the operating surgeon. No changes to surveillance methods or staff were made 
during this period. Surveillance staff, although not blinded to the introduction of the 
Antibiotic Prophylaxis policy, performed no role in its development or implementation such 
that policy introduction did not affect data collection.
We diagnosed SSI in accordance with CDC-NHSN definitions (12) within the constraints o f 
the diagnostic facilities available. All SSI diagnoses were based on clinical and radiological 
criteria - microbiological criteria were not used, although microbiology services at Thika 
Hospital were upgraded as part o f the surveillance project. All SSI diagnoses were discussed 
with the relevant surgical team and an infectious diseases physician. For analytic purposes, 
we only considered the single anatomically deepest form of SSI (organ-space > deep > 
superficial) diagnosed in a patient during the 30 day surveillance period.
As process indicators, we analysed the proportion o f patients undergoing surgical procedures 
who were documented to receive AP within 60 minutes o f  the start o f  the operation, and the
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proportion o f patients prescribed post-operative antibiotics. Using weekly datapoints (26 pre- 
and 40 post-intervention), we used segmented regression analysis to determine if there were 
significant step or slope changes in antibiotic prescribing behaviour associated with policy 
introduction.
As outcome measures, the risk o f different forms of SSI within 30 days o f the operation were 
recorded. We examined a time series plot o f monthly datapoints (6 pre- and 9 post­
intervention) for SSI risk. We looked for a step change associated with initial policy 
introduction and for overall trends in risk over time by performing linear regression analyses 
for the periods before (August 2010 -  January 2011) and after (March -  November 2011) 
policy introduction. In the absence o f aclear patterns to the month-to -m onth variation in SSI 
risk, the overall risk in these periods was compared in a before-and-after format by 
calculating a risk ratio. Patients whose surgery was classified as “Contaminated” or “Dirty” 
were considered separately as work in Thika Hospital (11) and elsewhere (1) has shown that 
high levels o f wound contamination to be strongly associated with increased SSI risk.
As balancing measures, we assessed financial costs and staff time requirements from the 
point o f view of a hospital administrator. Costs were evaluated by comparing the average cost 
(per 100 operations) for purchasing and administering intravenous (iv) antibiotics based on 
usage in Thika Hospital during surveillance. The monetary values of drugs and other 
consumables were obtained from the awarded prices for medical products in Thika Hospital 
for 2011-12. We estimated the difference in nurse-hours based on assumption o f an average 
o f 10 minutes of nursing time per dose of intravenous medication administered.
Ethics statement: SSI Surveillance at Thika Hospital was approved by the Kenya Medical 
Research Institute National Ethics Review Committee. All patients gave assent to 
participation in surveillance, which included contact by phone after discharge from hospital.
This study is reported in accordance with the ORION guidelines (13). All statistical analyses 
were done using STATA v l2  except for the segmented regression analysis which was done 
using SAS v9.
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Outcomes
Surveillance. We conducted SSI surveillance at Thika Hospital for all operations performed 
between the 16th August 2010 and the 20th November 2011 for patients who spent at least one 
post-operative night in hospital. We followed all patients for a 30-day post-operative period, 
with contact by telephone after discharge. A total of 3,343 patients were followed up in 
surveillance over this time, with the most commonly performed procedures being Caesarean 
section, hysterectomy, laparotomy and hernia repair.
Policy developm ent and implementation. As our intervention, we developed an Antibiotic 
Prophylaxis (AP) policy for Thika Hospital over a series o f  multi-disciplinary seminars held 
between November 2010 and January 2011. This was based on a review o f African (14-16) 
and international research (17) papers and relevant national policy documents. The resulting 
AP policy recommended that for most routine operations (including Caesarean sections, 
hysterectomies and laparotomies), a combination o f ampicillin (2g iv) and metronidazole 
(500mg iv) should be given pre-operatively and that no antibiotics should be prescribed post- 
operatively. No restrictions were placed on use o f  antibiotics for post-operative prophylaxis, 
but it was agreed that there was no evidence to support this practice. Full details o f the policy 
are given in Appendix 1; this policy was endorsed by all consultant surgeons and 
anaesthetists working at Thika Hospital, the Medicines+Therapeutics Committee and the 
Medical Superintendant. As there was no regular supply o f ampicillin from the Kenya 
Medical Supplies Agency (KEMSA) at this time, hospital pharmacists purchased this 
medicine locally.
Following extensive training o f medical, nursing and theatre staff, this AP policy was 
implemented in Thika Hospital from the 7th February 2011 onwards. Following an initial 
evaluation meeting, a patient information poster was used (Appendix 2) and personalised 
feedback was used to alert individual clinicians to substantial deviations from the practice o f 
their colleagues. We estimate that a total o f  approximately 600 hours o f staff time were used 
in meetings relating to development, implementation and evaluation o f the AP policy.
Results: process measures. In the pre-intervention phase o f this study (prior to Feb 2011), 
less than 2% o f patients were given pre-operative antibiotic prophylaxis -  this was only used 
for patients having orthopaedic procedures involving implanted material -  whilst over 99% o f  
surgical patients were prescribed post-operative antibiotic regimes, typically a combination o f 
penicillin, gentamicin and metronidazole given intravenously (iv) for three to five days,
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followed by a course o f oral antibiotics. The implementation o f the AP policy is illustrated in 
Figure 1, based on the weekly proportions o f patients undergoing Clean or Clean- 
Contaminated surgery. Documented adherence to the AP policy (in terms o f giving pre­
operative prophylaxis) was 60% in week 1 and 98% in week 6 o f policy introduction. Use of 
post-operative prophylactic antibiotics in Clean and Clean-Contaminated surgery fell to 40% 
in week 1 and 10% in week 6 o f policy introduction. Segmented regression analysis indicated 
that both the step change (p<0.0001) and the post-intervention downward trend (p=0.00l) 
were highly significant changes.
Results: outcome measures. Over the surveillance period, the monthly risk o f developing 
any form o f SSI (superficial, deep or organ-space) ranged between 3 and 13% in patients 
whose surgery was classified as Clean or Clean-Contaminated (see Figure 2) with marked 
month-to-month variation. With linear regression, there was no clear evidence of a trend in 
risk prior to policy introduction (6 monthly datapoints; monthly change: -0.5%; 95%CI -2.5 
to +1.4%, p=0.49). After policy introduction there was some evidence o f a downward trend 
in risk (9 monthly data points; monthly change: -0.7%; 95%CI -1.2 to -0.1%, p=0.027).
Evaluation o f the effects o f the AP policy on SSI risk in a before-and-after comparison 
showed reduction in the risk o f superficial SSI in both Clean/Clean-Contaminated surgery 
(RR 0.66; 95%CI 0.49-0.91; p=0.01) and in Contaminated/Dirty surgery (RR 0.17; 95%CI
0.04-0.74; p=0.005) -  see Table 2. Changes in the risk o f deep or organ-space SSI were 
found to be non-significant (p>0.1).
Results: balancing measures. The financial and time impacts associated with the 
introduction of the AP policy in Thika Hospital, based on recorded usage before and after AP 
policy introduction are given in Table 3. There was a net reduction in the costs for iv 
antibiotics and associated consumables o f approximately $2.50/operation, and the number of 
iv injections administered and the nursing time spent performing these were both reduced by 
approximately 70%, leading to a saving o f approximately 450 nurse-hours per month.
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Discussion
We believe this is the first report o f implementation of a quality improvement intervention in 
antibiotic use accompanied by process, outcome and balancing measures reported from sub- 
Saharan Africa. It is also the largest single-institution study o f SSI risk in this region.
Our intervention, a locally-developed surgical antibiotic prophylaxis policy, rationalised 
clinicians’ prescribing, substantially reduced the use o f intravenous antibiotics and saved both 
money and nursing time. Furthermore, there was some evidence o f a modest reduction in risk 
of superficial SSI across all levels o f wound contamination (RR 0 .66 ,95%CI 0.49-0.91 in 
Clean/Clean-Contaminated surgery; RR0.17, 95%CI 0.04-0.74 in Contaminated/Dirty 
surgery).
We note that there was marked month-to-month variation in the overall risk o f SSI during 
surveillance, principally due to changes in the recorded risk o f superficial SSI. The highest 
overall risk o f SSI was seen in the month of February 2011: this was both the month o f the 
AP policy implementation and also the month that the annual intake o f newly qualified junior 
doctors commenced work in Thika Hospital in 2011. This may have obscured the immediate 
effect o f the changeover in AP use and may also account for the spike in SSI cases that 
occurred that month. Junior doctors (who perform the majority o f uncomplicated Caesarean 
sections) rotated between hospital departments on a 3-monthly basis throughout the 
surveillance period; no other changes in staffing levels, equipment, facilities or operative 
techniques took place in Thika Hospital during this period.
Lim itations: Surgical Site Infections are inherently difficult to measure -  these must be 
detected over a prolonged post-discharge period and largely rely on clinical judgement for 
diagnosis. We believe the outcomes measured in this study were assessed objectively and that 
we achieved the best level o f post-discharge follow-up that is feasible for SSI surveillance in 
this setting.
Although this study represents the largest report o f  SSI surveillance in a single institution in 
sub-Saharan Africa, it still remains relatively small in comparison to SSI surveillance studies 
in high-income settings. There are not sufficient data points in this surveillance to determine 
if  there were cyclical patterns to SSI risk which could relating to hospital crowding or 
changes in average levels o f staff experience. Some circumstantial evidence, as described 
above, suggests that the latter could be important. This could be contributing bias to this 
study, though this would probably lead to underestimation of the effectiveness o f the
43
Chapter 3
intervention as junior doctors were, on average, less experienced in the period after policy 
introduction. The numbers of patients undergoing surgery that was classified Contaminated 
or Dirty operations was small, typically between 5 and 15 operations per month, so there 
were insufficient data to evaluate the effects o f  the intervention on these procedures.
Selection o f antibiotics for use in the AP policy in Thika Hospital was difficult. Gentamicin 
was not used due to concerns about possible interactions with long-acting muscle relaxants. 
Co-amoxiclav might have been a better agent (15) as resistance to amoxicillin/ampicillin is 
widespread in Kenya (18) which might have lead to a more pronounced reduction in the risk 
o f  SSI, but at greater cost.
B arriers and pathw ays to change. Inappropriate antibiotic use is a multi-dimensional 
problem. What barriers existed to prevent this change in timing o f  antibiotic prophylaxis 
being implemented in Thika Hospital prior to 2011, when both research evidence and 
national guidelines supported such a change? Firstly, there was very limited awareness o f 
national clinical policy documents, resulting in a marked policy-to-practice gap. Secondly, 
there was poor access to appropriate medicines for surgical prophylaxis -  for example, 
although the Kenya Essential Medicines List describes ampicillin as “essential” for 
Government hospitals, in practice, this antibiotic was never received from official suppliers. 
Thirdly, amongst clinicians there was a marked concern about negative outcomes, especially 
regarding nosocomial infections, that hindered changes in antibiotic usage. The belief that 
prolonged post-operative antibiotic use mitigated the risk o f HAI (in turn principally ascribed 
to overcrowding and poor hygiene) was widespread. Finally, there was a lack o f awareness 
amongst hospital management o f the overall potential for cost-savings associated with such a 
policy change.
Why did this AP policy intervention succeed in changing local practice and sustaining this 
throughout the study period? Contributing factors to success were:
1) A strong evidence base -  including some local studies -  to support the proposed changes 
and national infection control guidelines were already in place.
2) “Buy-in” to this project from senior clinicians and hospital management
3) Collaborative policy development involving staff from different professions and 
departments.
4) Locally-relevant written training materials for both staff and patients.
5) Extensive staff and patient sensitization prior to an after implementation.
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6) Data collection for both process and outcome measures with timely feedback, including 
personalized feedback to persistent policy non-compliers.
7) Upgrade of SSI microbiology services as part of surveillance.
8) An appreciable saving o f nurse-time and resources as a result of policy implementation.
Informal feedback from staff at Thika Hospital suggested that factors 5 and 8 were judged to 
have been most important, but all other factors played a contributing role. The change in 
practice with regard to use o f surgical prophylaxis was reported to have been sustained as o f  
August 2012, although no further data were collected.
Conclusion
Antibiotic stewardship, evidence-based practice and infection control are all important issues 
in healthcare. Achieving lasting improvements in any one of these fields is difficult -  but this 
intervention made an improvement in a typical Government hospital in Kenya in all three 
areas whilst also saving both nursing-time and resources. Many factors contributed to 
achieving successful implementation o f policy -  most importantly, local engagement with 
clinicians and support o f the process of change.
Our report demonstrates that changing from the outdated practice o f post-operative 
prophylaxis is an achievable quality improvement intervention for hospitals in low-income 
settings. The looming threat o f widespread antibiotic resistance means that there is a pressing 
need to improve antimicrobial use in low-resource settings (19). Better use o f antibiotics for 
surgical prophylaxis is a “low-hanging fruit’’(20) that is worth picking for antibiotic 
stewardship programmes in hospitals in sub-Saharan Africa.
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Table 1 -  Overall risk of SSI with and without use of pre-operative antibiotic prophylaxis
Surgical Site Infections
Post-operative 
antibiotics only 
(%)
Pre-operative AP 
+/- post-operative 
antibiotics (%)
Risk Ratio 
(95%CI) p-valuea
Clean and Clean-Contam inated surgery
number o f operations 1,130 (100) 2,046 (100) -
superficial 69 (6.1) 83 (4.1) 0.66 (0.49-0.91) 0.01
deep 10 (0.9) 13 (0.6) 0.72 (0.32-1.63) 0.43
organ-space 3 (0.3) 6 (0.3) 1.10(0.28-4.41) 0.89
to talb 82 (7.3) 102 (5.0) -
Contam inated and D irty surgery
number o f operations 76 (100) 91 (100) -
superficial 10 (13.2) 2 (2.2) 0.17(0.04-0.74) 0.006
deep 6 (7.9) 13 (14.3) 1.81 (0.72-4.53) 0.20
organ-space 2 (2-6) 2 (2.2) 0.83 (0.12-5.79) 0.86
to talb 18 (23.7) 17 (18.7) -
a = p-value from x2-test with 1 degree o f freedom.
b = no RR calculated for all SSI combined as these represent diverse forms o f infection
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Item
Baseline 
August 2 0 1 0 - 
Jan 2011
Intervention 
April 2011 — 
Nov 2011
Change associated with 
AP policy (% change 
from baseline)
Costs (US$)
All iv antibiotic agents used f 394.21 293.14 -101.07 (-26)
Consumables for iv administration 223.01 71.02 -151.99 (-68)
Total costs 617.22 364.16 -253.06 (-41)
O ther im pacts
Doses o f  iv medications (number) 1221 367 -854 (-70)
Nursing time giving iv antibiotics (hrs)* 204 61 -143 (-70)
Exchange rate o f Ksh85 = US$1 used
f  based on documented prescriptions and number o f doses administered in these time-periods 
* based on an estimate o f 10 minutes o f  nursing time / dose o f iv medication.
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Figure 5: Weekly prescribing practices for surgical antibiotic prophylaxis
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Figure 6: Monthly risk of SSI in Thika Hospital, 2010-11
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Appendix 1:
Thika L5 Hospital Surgical Antibiotic Prophylaxis (AP) Policy
START: Patient in WARD/ CASUALTY
CONSLTLTANT / MO / MOI makes decision that patient is for operation
I---------------------------
MOI /MO/CO inserts cannula for 
patient on morning o f  Operation 
(Elective Surgery) or as soon as 
decision to operate is made 
(Emergency Surgery).
This must be 18G size or larger.
MOI/ MO/CO writes a 
prescription for pre-operative 
AP on Treatment sheet
WARD NURSE checks the 
prescription has been written 
as part of Pre-Op Checklist and 
checks for drug allergies
WARD NURSE issues antibiotic 
prophylaxis (AP) drugs from ward 
stock. If unavailable on ward, NURSE 
requests AP drugs from PIIARMACY 
on a named patient basis. If 
PHARMACY out of stock, patient or 
relatives must buy AP drugs
When MAIN/MATERNITY THEATRES ready to receive patient 
(ideally 30-45 mins prior to start o f  operation)
WARD NURSE transfers patient with 
cannula, prescription and AP drugs to THEATRE
RECEIVING NURSE in THEATRE only accepts 
patient if cannula, prescription and AP drugs are 
brought with the patient from the ward.
ANAESTHETIST confirms patient is fit for 
operation and the prescription for AP is appropriate
WARD NURSE 
records AP drugs 
dispensed in ward 
antibiotic book.
*
FINISH
Key:
WARD NURSE checks 
proscription has been written.
Each box describes a responsibility that a STAFF MEMBER has in the 
process of administering antibiotic prophylaxis (AP).
Pre-operative Antibiotic Prophylaxis for Surgical Patients in Thika Level 5 Hospital
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Thika L5 Hospital S u rg ic al Antibiotic Prophylaxis (AP) Policy
i n  Grouts 1 lill,lllll,lll“ ^Operatio  r p Antibiotics for 
PROPHYLAXIS
^ ■ 3  \ r » i  y f  u i l t  j
Dose Timing
Caesarean section: Elective OR Emergency*
*=  Unless ruptured uterus / Prolonged ROM / Prolonged 
labour / other complication -  see below
Ampicillin 2g 
Flagyl SOOmg
Single pre-op dose, 
no post-operative antibiotics
Gynaecological Surgery -m ajor procedures 
(eg hysterectomy, oophorectomy, cystectomy )
Ampicillin 2g 
Flagyl SOOmg
Single pre-op dose, 
no post-operative antihiotlr«
General Surgery "abdominal"
(eg laparotomy, appendisectomy (if no perforation), 
biliary tract surgery, colorectal surgery
Ampicillin 2g 
Flagyl SOOmg
Single pre-op dose, 
no post-operative antibiotics
General Surgery "non-abdominal”
(eg hernia repair, mastectomy, thyroidectomy, burns 
grafting, fasciotomy)
Ampicillin 2g Single pre-op dose, 
no post-operative antibiotics
CLEAN Orthopaedic surgery and Neurosurgery 
(eg ORIF, craniotomy, interlocking nail)
Ceftriaxone 2g Single pre-op dose, 
no post-operative antibiotics
EYE Sureerv -  Extensive EYE ODerations
(eg. Dacryocystorhinostomy (DCR), Enucleation of eye,
repair of major eye trauma)
Ampicillin 2g 
Flagyl SOOmg
Single pre-op dose.
Give post-op Gentamycin + 
steroid eye drops
local EYE surgery (cataract removal, glaucoma surgery)
Subconjunctival Gentamycin 
injection at end of op.
Give post-op Gentamycin 
+steroid eye drops
ENT Sureerv -  Extensive ENT ooerations 
(eg parotidectomy, thyroglossal cyst removal)
Ampicillin 2g 
Flagyl SOOmg
Single pre-op dose, 
no post-operative antibiotics
Local ENT operations (eg. Tonsillectomy, adenoidectomy) No pre-operative AP Post-op oral augmentin or 
azithromycin
Minor Gynaecology Procedures (on Ward or in theatre) 
Eg. MVA, D+C.
(ESB and MacDonald stitch do not require AP)
Ampicillin 2g 
Flagyl SOOmg
Single dose before procedure. 
Nil further treatment.
ANY Contaminated or Dirty/lnfected operation
Including
• Surgical Toilet, Abscess drainage, arthrotomy for septic 
arthritis, traumatic wound closure, any gastro­
intestinal perforation, amputation for gangrene.
• CJS with ruptured uterus/ Macerated Stillbirth/ 
PROM/Prolonged Labour.
• Any patient with an infection at the time of surgery (eg 
chorioamnionitis, infected wound, abscess).
Ampicillin 2g 
Flagyl 500mg
Pre-operative PROPHYLAXIS 
AND then to received 
TREATMENT after operation 
as per clinicians prescription.
Patient with reported allergy to penicillin, for any surgery
•Note: there is a small risk of cross-allergy between 
Penicillins and Cephalosporins (approx 10% risk)
Omit Ampicillin from AP 
if good history of allergy. 
Can use Ceftriaxone* (2g) 
instead if necessary.
Single pre-op dose, 
no post-operative antibiotics
.  Patients should receive pre-operative Antibiotic Prophylaxis even if they are already on antibiotic treatment 
on the wards- these medicines are very unlikely to cause significant overdose.
•  For children under the age o f  10 years or adult patients less than 30kg, doses o f antibiotics should be 
adjusted to the weight of the patient as follows: Ampicillin 50mg /kg, Metronidazole 7.5mg /kg
•  Repeat doses of AP should be given in operations lasting > 4 hours, or if major blood loss occurs
•  No additional post-operative treatment is required for immunosuppressed patients unless they have 
“Contaminated” or “Dirty” operation sites.
.  Ampicillin is for use as Antibiotic Prophylaxis in Surgical patients. If an infection subsequently develops 
after surgery, different antibiotics should be prescribed for treatment o f  the infection as the organism(s) may 
be Ampicillin resistant. First line treatment for wound infections should be X-nen. fient.-imicin. Fl.nn l
.  No oral antibiotics are needed on discharge if a patient had pre-operative AP and has no'signs of wound 
infection at time of discharge. Prescribing further antibiotics wastes money and promotes drug resistance'
Pre-operative Antibiotic Prophylaxis for Surgical Patients in Thika Level 5 Hospital
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Appendix 2: Patient education poster in Kiswahili and English.
Dawa baada ya upasuaji ?
r
/
• w
fcg F
fT¡ ' l r
Hivi karibum, hospital: ya Thika imebadilisha mfumo wa utumizi wa 
dawa kwa wagonjwa wanaofanytwa upasuaji.
Hapo mbelem, wagonjwa walikuwa wakipewa dawa za kukabiliana 
na baktiria kwa njia ya sindano pamoja na tembe kwa siku kadha 
BAADA ya upasuaji ill kuzuia maambukizi. Utaratibu huu unafuatwa 
katika hospitali nymgi kote nchini lakini ni mfumo wa kutumia hizi 
dawa uliopitwa na wakati.
Kwa sasa, wagonjwa katika hospitali ya Thika wanapewa DOZI MOJA 
ya dawa za kukabiliana na baktiria KABLA ya upasuaji, kuambatana 
na mwongozo uliotolewa na kanuni za kitaifa za matibabu (National 
Clinical Guidelines) 2009. Desturi ya kutumia dawa za kukabiliana na 
baktiria baada ya upasuaji haimo tena.
Kwa hiyo.wengi wa wagonjwa hawahitaji dawa za kukabili baktiria 
baada ya upasuaji, ziwe za sindano au za tembe. Unahitaji kuzitumia 
hizi dawa baada ya upasuaji iwapo yamezuka maambukizi kwenye 
kidonda chako baada ya upasuaji. Unaweza kutumia dawa zingme 
kama paracetamol na diclofenac kwa minajili ya kupunguza maumivu 
baada ya upasuaji. hill halitaathiri kupona kwa kidonda chako.
Idadi ndogo ya wagonjwa ambao tayari wana maambukizi wakati wa 
upasuaji watapewa dawa za kukabili baktiria baada ya upasuaji ili 
kulitibu ambukizi hili. Daktari wako atafanya uamuzi iwapo utahitaji 
matibabu haya.
Thika Hospital has recently changed the way that 
medicines are used for patients having surgery.
Previously, patients were given antibiotic injections and 
tablets for several days AFTER the operation to prevent 
infections. This is used in hospitals nationwide, but this is 
an old-fashioned way of using these medicines.
Now, patients in Thika Hospital are given a SINGLE DOSE of 
antibiotics IMMEDIATELY BEFORE the start of the operation 
-  this is what is advised by the National Clinical Guidelines 
(2009). No antibiotics are routinely used after surgery.
So, most patients do not need any antibiotics after their 
operation, either as injections or as tablets. You only need 
to have antibiotics after your operation if an infection 
develops in your wound after the operation. You can still 
take medicines such as paracetamol or diclofenac to 
reduce pain after your operation -  this will not affect the 
healing of your wound.
A small number of patients who already have an infection 
at the time of their operation will be given antibiotics after 
the operation to treat this infection. Your doctor will 
decide if you need to have this treatment.
Thika Hospital -  Infection Prevention+Control Committee, May 2011
Title translates to “Medicines after surgery?”
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Technical Appendix
An assumption of linear regression is that the data series is normally distributed ( -1 < skew < 
1 AND -1 < kurtosis < 1). Before the post-operative antibiotic prescribing series was 
analysed using segmented regression, a check was made to assess the normality of the series. 
When the data was found to be non-normal (kurtosis = -1.759), we also explored the use of 
fortnightly and monthly time points.
Post Op Prophylaxis Given Skew Kurtosis
Weekly Time Points 0.413 -1.759
Log Weekly Time Points -0.396 -0.679
Fortnightly Time Points 0.473 -1.799
Log Fortnightly Time Points 0.054 -1.510
Monthly Time Points 0.715 -1.619
Log Monthly Time Points 0.254 -1.477
The time series of weekly data points is not normally distributed, and collapsing data to 
fortnightly or monthly time points did not achieve normalisation. The underlying reason for 
this non-normality is likely to be the large scale of the effect of the intervention -  essentially 
this makes the data points appear bimodal, which then gives the high degree of kurtosis 
(“peakedness”) seen above. Therefore, a log transformation was performed to achieve 
normality (skew = -0.396, kurtosis = -0.679) in weekly datapoints.
Segmented regression analysis was performed on the log transformed series to assess pre 
intervention trend, change in level and change in trend. As the series has been log
transformed the direction of the change (+ or -) only can be determined and assessed for 
statistical significance.
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Log transformed Regression 
Co-efficients
p-value
Intercept 4.6054 <0.0001
Trend (Before Intervention) -0.001772 0.8623
Change In Level -1.1727 <0.0001
Change In Trend -0.0360 0.0010
These results indicate that there was no statistically significant change in % of patients 
receiving post-operative antibiotics before the intervention which is fairly static at -96%. 
There was a statistically significant decrease in level (-1.1727, p<0.0001) which indicates an 
abrupt intervention effect. There was a statistically significant change in trend (-0.0360, 
p=0.0010) following the intervention which indicates a gradual intervention effect.
As the data series has been log transformed the data series is not appropriate for use in the 
Multivariate Delta Method (as described by Zhang et al, J Clin Epi 2009) so it is not possible 
to construct confidence intervals around the intervention effects.
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Risk and causes of paediatric hospital-acquired bacteraemia 
in Kilifi District Hospital, Kenya: a prospective cohort study
Alexander M  Aiken, Neema Mturi, Patricia Njuguna, Shebe Mohammed, James A Berkley, Isaiah Mwangi, Salim Mwarumba, Barnes S Kitsao, 
Brett S Lowe, Susan C Morpeth, AndrewI Hall, Iqbal Khandawalla,) Anthony G Scott, Kilifi Bacteraemia Surveillance Group*
Summary
Background In sub-Saharan Africa, community-acquired bacteraemia is an important cause o f illness and death in 
children Our aim was to establish the magnitude and causes o f hospital-acquired (nosocomial) bacteraemia in 
African children. '
Methods We reviewed prospectively collected surveillance data o f 33188 admissions to Kilifi District Hospital, Kenya, 
between April 16, 2002, and Sept 30, 2009. We defined bacteraemia as nosocomial if  it occurred 48 h or more after 
admission. We estimated the per-admission risk, daily rate, effect on mortality, and microbial cause o f nosocomial 
bacteraemia and analysed risk factors by multivariable Cox regression. The effect on morbidity was measured as the 
increase in hospital stay by comparison with time-matched patients without bacteraemia.
Findings The overall risk o f  nosocomial bacteraemia during this period was 5-9/1000 admissions (95% Cl 5-2-6-9) 
but we recorded an underlying rise in risk o f 27% per year. The incidence was 1 0/1000 days in hospital (0 • 87-1 • 14), 
which is about 40 times higher than that o f community-acquired bacteraemia in the same region. Mortality in patients 
with nosocomial bacteraemia was 53%, compared with 24% in community-acquired bacteraemia and 6% in patients 
without bacteraemia. In survivors, nosocomial bacteraemia lengthened hospital stay by 10 • 1 days (3 • 0-17 • 2). Klebsiella 
pneumoniae, Escherichia coli, Staphybcoccus aureus, Acinetobacter spp, group D streptococci, and Pseudomonas 
aeruginosa accounted for three-quarters o f nosocomial infections. Nosocomial bacteraemia was significantly associated 
with severe malnutrition (hazard ratio 2-52, 95% Cl 1-79-3-57) and blood transfusion in children without severe 
anaemia (4-99; 3-39-7-37).
Interpretation Our findings show that although nosocomial bacteraemia is rare, it has serious effects on morbidity 
and mortality, and the microbiological causes are distinct from those of community-acquired bacteraemia. Nosocomial 
infections are largely unrecognised or undocumented as a health risk in low-income countries, but they are likely to 
become public health priorities as awareness o f their occurrence increases and as other prominent childhood diseases 
are progressively controlled.
Funding Wellcome Trust.
In t r o d u c t io n
“Health-care-associated infection in developing 
countries is a serious issue that is scarcely addressed in 
the scientific literature”.1 In sub-Saharan Africa, 
community-acquired paediatric bacteraemia imposes a 
major health burden.2-4 However, almost no regional 
information is available about hospital-acquired 
(nosocomial) bacteraemia. The WHO Patient Safety 
programme7 did a systematic review o f  health-care- 
associated infection in developing countries between 
1995 and 2008 and found no reports about nosocomial 
bacteraemia in adults or children in Africa, and only five 
studies o f  paediatric nosocomial bacteraemia from  
developing countries worldwide. A review focusing on 
infections in hospital-born neonates suggested a high 
risk o f  disease in this age group across the region.' 
Untreated maternal HIV infection is an important risk 
factor for neonatal nosocomial sepsis.’ Outbreak 
reports1“'12 show that this disease occurs in the region 
but do not provide the denominator data necessary for 
estimation o f  risk or incidence.
We aimed to assess the risk, rate, effect on mortality 
and morbidity, microbiological causes, and risk factors 
for paediatric nosocomial bacteraemia by analysing 
surveillance data obtained prospectively for a continuous 
period at one Kenyan hospital.
Methods
Study design and patients
Kilifi District Hospital is in a rural area in Coast Province 
o f Kenya. The Kenya Medical Research Institute- 
Wellcome Trust Research Programme has undertaken 
surveillance for invasive bacterial disease in children 
admitted to this hospital for more than a decade. Further 
information about Kilifi District Hospital is available in 
the webappendix. Throughout the analysis period 
between April 16, 2002, and Sept 30, 2009, we obtained 
specimens from all paediatric inpatients (except those 
with minor trauma or undergoing elective surgery) to 
investigate clinical illness both on admission and during 
the hospital stay. All children (except those described 
above) admitted to the paediatric ward were investigated
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with blood cultures on admission. We systematically 
obtained detailed clinical and laboratory information 
from all patients at admission. We used WHO standard 
techniques to take anthropometric measurements and 
we calculated weight-for-age 2  scores using American 
National Centre for Health Statistics reference data.
We investigated patients with persistent or new fever, 
or clinical deterioration after admission, with a septic 
screen consisting o f  blood cultures, urine testing, and 
other samples as clinically indicated. Blood samples were 
taken by the admitting clinician, or by a ward aide (ie, 
a clinical support worker with phlebotomy training) after 
cleansing o f the child’s skin with 70% alcohol. Blood was 
inoculated into a culture bottle (BACTEC Peds Plus, 
Becton Dickinson, Franklin Lakes, NJ, USA) after the top 
o f the bottle had been disinfected. We used an automated 
culturing system (BACTEC 9050, Becton Dickinson) to 
process blood cultures. We subcultured positive samples 
onto standard media and used standard microbiological 
techniques to identify the microorganisms. Laboratory 
procedures were internally controlled, and quality was 
monitored externally by the UK National External Quality 
Assessment Service. The monthly performance score for 
culturing o f simulated specimens and identification o f  
test organisms was higher than 95%.
Our study included an analysis of bacterial surveillance 
data that were drawn from two studies o f invasive bacterial 
diseases at Kilifi District Hospital. Parents or guardians o f  
all patients gave written informed consent for participation 
in these studies, which included cultures of blood taken 
at admission and routine investigations o f clinical care. 
Both studies were approved by the Kenya Medical 
Research Institute National Ethics Review Committee.
Case definition
We defined an episode o f nosocomial bacteraemia as 
isolation o f  a pathogenic organism (bacterial or fungal) 
from the blood of a child when the sample was taken 
more than 48 h  after admission. We classified bacter­
aemia on readmission (within 28 days of discharge or 
hospital birth) as health-care-associated and all other 
positive blood cultures as community acquired. We 
regarded repeated isolation o f  the same pathogen in 
blood cultures within 14 days as one disease episode, 
whereas we regarded isolation o f  a different pathogen 
as a distinct disease episode. Coagulase-negative 
staphylococci, Bacillus spp, Micrococcus spp, viridans 
group streptococci, and coryneform bacteria were 
regarded as contaminants.
Statistical analysis
We did analyses in STATA version 11.0. We calculated the 
risk o f  at least one episode o f  nosocomial bacteraemia 
per admission and the incidence per 1000 days of 
inpatient hospital stay. We used log-linear binomial 
regression to characterise trends in the yearly risk of 
nosocomial bacteraemia and the probability o f identifying
a pathogen if a blood sample for culture had been taken. 
We analysed change in duration o f hospital stay by year 
using Cox regression.
We used multivariable Cox regression to investigate 
the association o f  risk factors with the development o f  
nosocomial bacteraemia. This approach is independent 
of length of hospital stay and is suitable for analysis o f  
nosocomial infections in inpatient cohort data" even if  
the outcome is rare.14 We used adjustment o f variance 
for clustering within individuals with several 
admissions, and log-log plots for each variable to 
graphically confirm the validity o f the proportional 
hazards assumption. We converted risk factor data, 
originally recorded in continuous variables, to binary or 
categorical variables before examining the effects o f  
risk factors. Variables were included in a multivariable 
model if  they showed a univariate association o f  p<0-1. 
We tested for interactions between biologically 
associated variables in the final model.
To produce unbiased estimates o f the additional length 
of hospital stay attributable to nosocomial bacteraemia, 
we used a confounder and time matching approach.14 
When possible, we randomly selected four patients who 
survived to discharge without nosocomial bacteraemia 
and matched by age and nutritional status to a patient 
with nosocomial bacteraemia, with the further constraint 
that they had been in hospital at least as long as the index 
patient at the point he or she developed bacteraemia. With 
an assumed mean hospital stay of 20 days (SD 25 days) in 
unexposed patients, matching o f four patients to each 
case provides more than 90% power to detect an increased 
duration of 10 days in the exposed group.
Role of the funding source
The sponsors o f the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had final 
responsibility for the decision to submit for publication.
Results
35143 admissions were made to Kilifi District Hospital in 
the study period, o f which 1316 (4%) were excluded 
because no blood was taken for culture, and 639 (2%) 
were excluded because o f  missing data or errors in 
the dates of admission or discharge. We analysed 
33188 admissions (94%) in 26721 patients.
The median length o f hospital stay was 3-7 days 
(IQR 2-0-6-8  days) and the median age at admission 
was 1-3 years (range 0 days to 15 years, IQR 157 days to 
3-0 years). About 14% o f the children admitted were 
neonates (age s28 days, table 1), though the proportion 
increased from 11% (904 of 8547) in 2002-03 to 18% 
(1219 o f 6889) in 2008-09.
We identified 212 episodes of nosocomial bacteraemia. 
13 children had two episodes and one child had three 
episodes during the same admission, so the total number
Published online November 30.2011 DOI:10.10l6/S0140-6736(ll)6l622-X
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of admissions with at least one episode of nosocomial 
bacteraemia was 197. Most episodes o f nosocomial 
bacteraemia were preceded by one or more negative 
blood cultures (88%, 186 o f 212) or by an admission blood 
culture isolating a different pathogen (5%, 11 of 212), 
supporting the inference of hospital-acquired disease. 
The risk of development of nosocomial bacteraemia at 
least once during a hospital stay was 5-9 per 
1000 admissions (95% Cl 5 • 2-6 • 9).
We included 212933 inpatient days of observation in the 
study period, giving an overall rate of nosocomial 
bacteraernia o f 1-00 episode per 1000 person-days 
(0-87-1-14) or 36340 episodes per 100000 person-years 
(31777-41639). In  children younger than 2 years 
at admission, the rate was 42398 episodes per 
100000 person-years (36222-49626). The estimated 
incidence of community-acquired bacteraemia in children 
younger than 2 years living in the same community is 
1080 per 100000 person years,' which suggests that the 
incidence rate ratio for acquisition of bacteraemia in 
hospital compared with in the community is about 40. The 
rate of nosocomial bacteraemia was higher than at baseline 
(day 2-7) in the second week (relative risk [RR] 1 - 61,95% Cl 
1-16-2-23) and third week (1-77, 1 -18—2■ 66) of hospital 
stays but not thereafter. The rate of nosocomial bacteraemia 
increased progressively throughout the study from 0 • 59 per 
1000 person-days (95% Cl 0-44-0-78) in 2002-04, to 
1 - 66 per 1000 person-days (1-34-2-04) in 2008-09. The 
number of blood samples for culture taken more than 48 h 
after admission increased progressively from 163 in 2003, 
to 408 in 2008, with an annual increase of 19% (17-22%). 
Duration of hospital stay also increased throughout the 
study period. The average annual increase in duration of 
admissions was 3 -8%  (3-3-4-4%); the median duration 
was 3 -15 days (IQR 1-90-5-92) in 2002 and 3-98 days 
(2-06-7-96) in 2009. We recorded no difference in this 
trend when the analysis was restricted to children who 
survived to discharge. The probability of detection of 
nosocomial bacteraemia when blood samples were taken 
more titan 48 h after admission increased slightly during 
the study (RR per year=l-07, 95%  Cl 1-00-1-14).
Table 1 shows the distribution of children with 
nosocomial bacteraemia by each risk factor, together with 
univariable hazard ratios (HRs). Notably, nosocomial 
bacteraemia was not associated with age group (p=0 -18). A 
multivariable proportional hazards model showed 
significant effects for nutritional status defined in terms of 
weight-for-age Z  score, prescription of a blood transfusion, 
and study period. We recorded a significant interaction 
between transfusion and severe anaemia. To elucidate the 
factors behind this interaction, we re-examined the 
multivariable model in two exclusive age strata, patients 
aged 28 days or younger (neonates), and patients older 
than 28 days (infants and children). The pattern of risk 
factors differed sufficiently between these strata to justify 
separate presentation of the results (table 2). Severe 
anaemia and blood transfusion were not risk factors for
nosocomial bacteraemia in neonates. In  infants and 
children, blood transfusion (as prescribed at admission) 
was a highly significant risk factor for nosocomial 
bacteraemia, but only in children who did not have severe 
anaemia (table 2). Poor nutritional status was a risk factor 
at all ages but it showed a more pronoimced association in 
neonates than in infants and children (table 2).
In 197 patients who developed one or more episodes 
of nosocomial bacteraemia, the case-fatality rate was 53% 
(105 of 197; 95%  Cl 46-60), compared with 24% 
(372 of 1528; 22-26) in patients with community-acquired
N u m b e r  o f  a d m is s io n s  O u tc  
( %  o f  a ll a d m is s io n s )  e ve n
A g e  g r o u p
0-28 days 4668(14%) 53
29-59 days 1056(3%) 6
60-365 days 8275(25%) 49
Older than 366 days 19189(58%) 104
Sex
Female 14552 (44%) 97
Male 18636(54%) 115
N u tr it io n a l s t a t u s  ( W A Z )
>-3 26050 (79%) 78
-3 to -4 4179(13%) 52
<-4 2692 (8%) 77
Missing 267(1%) 5
H IV  s t a t u s
Known negative 8150(25%) 71
Known positive 696(2%) 20
Unknown 24342(73%) 121
T r a n s fu s io n  p re sc r ib e d
No 30563(92%) 153
Yes 2573(8%) 58
Unknown 52 (<1%) 1
Se ve re  m a la r ia *
No 30205(91%) 208
Yes 2789(9%) 4
S e ve re  a n a e m ia t
No 30132(91%) 189
Yes 2167(7%) 11
Unknown or not tested 889(3%) 12
B u rn s  o n  a d m is s io n
No
32724(99%) 202
Yes 464(1%) 10
T im e  a d m it te d
2002-04 13300(40%) 48
2005-07 12 998(39%) 78
2008-09 6890(21%) 86
T o ta l
All admissions 33188(100%) 212
U n iv a r ia b le  h a z a rd  r a t io  
( 9 5 %  C l)
138(0 97-194) 
118(0 46-3 00) 
140 (0 97-201) 
10
10
0 98(074 131) 
10
2 06(142-2 99)
2 52 (179-3 57)
3 52 (120-10 29)
10
160(0 97-2 66) 
0 67(0 49-0 92)
10
2 73 (198-3 76)
3 90(0 53-28 7)
10
0 45 (013-1-51)
1 0
075 (040-1 43) 
2 00 (0 97-4 14)
10
0 81(041-160) 
10
1 58(107-2 32)
2 53(1 74-3 68)
W A Z = w e ig h t -fo r -a g e  Z  score. "D e fin e d  a s per W H O  criteria“  fo r clinically severe  m alaria. tD e fin e d  as h a e m og lo b in  
< 5 0  g/L (fo r  pa t ie n ts o lder th a n  2 8  d ay s) o r h a e m o g lo b in  < 9 0  g/ t  (fo r neonates).
Table 1: R is k  f a c to r s  in  s t u d y  p a t ie n t s  a n d  u n iv a r ia b le  h a z a rd  ra t io s
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Articles
Age younger than 28 days* 
(HR [95% Cl])
Age older than 28 days 
(HR[95%CI])
Nutritional status (WAZ)
>-3 100
100
-3 to -4 1-73 (0 71-4 23)
199(131-3 04)
3 40(160-7 26) 195(1 29-2 97)
Missing 5 22 (0 93-29 4)
178 (0-42-7 48)
Severe anaemia and transfusion
No severe anaemia, not transfused 100
Severe anaemia, not transfused 104(0-33-3-26)
No severe anaemia, transfused 4 99(3 39-7 37)
Severe anaemia, transfused 0 62 (0-23-166)t
Time admitted
2002-04 100
100
2005-07
187(0 73-4 82) 143(0 93-2 20)
2008-09 2 34 (0 89-614)
2 01 (1 29-3 12)
Severe anaemia and receipt o f  a blood transfusion had no significant effect in neonates and were not included in this 
model for this age group. W AZ-weight-for-age Z  score. HR=hazard ratio. 'Patients with missing data for blood 
transfusion or anaemia status on admission were excluded from this analysis.tLikelihood ratio test for inclusion of 
interaction term has p -0  015.
Table 2: Risk factors for nosocomial bacteraemia analysed with multivariable Cox regression models
Nosocomial 
(total [%])
Health-care- 
associated* 
(total [%])
Community- 
acquired 
(total [%])
Gram-negative organisms
Escherichia coli 44(21%) 16 (11%) 144(9%)
Proteus mirabilis 3(1%) 1(1%)
6 (<1%)
Klebsiella pneumoniae 43(20%) 2(1%)
37(2%)
Klebsiella spp (other) 9(4%) 1(1%) 5 (<1%)
P se u d o m o n a s  ae ru g in o sa 16 (8%) 8(6%) 31(2%)
P se u d o m o n a s  s p p  ( o th e r ) 3(1%) 1(1%) 24(2%)
A c/n e to b a c te r  sp p 19(9%) 12(9%) 159 (10%)
Non-typhi Salmonella spp 3(1%) 10(7%) 136(9%)
Salmonella typhi 2(1%) 0(0%)
12 (1%)
Other enterobacteriaceae 8(4%) 4(3%) 26(2%)
Haemophilus influenzae 2(1%) 4(3%) 99(6%)
Other Gram- negative organisms 4(2%) 0(0%) 59(4%)
Gram-positive organisms
Staphylococcus aureus 20(9%) 22 (16%) 198(13%)
Streptococcus p n e u m o n ia e 3(1%) 23 (16%) 459(29%)
Group A streptococci 1(1%) 5(4%) 71(5%)
Group B streptococci 2(1%) 18 (13%)
26 (2%)
Group D streptococci 18 (9%) 12 (9%) 53(3%)
Other gram-positive organisms 1(1%) 2(1%) 37(2%)
Fungi
Yeasts 11(5%)
1(1%) 8(1%)
Total pathogens 1 212 (100%)
141 (100%) 1590 (100%)
Data are number o f  episodes. 'Healthcare-associated infection was defined as bacteraemia within the first 48  h of 
admission to  hospital when within 28 days o f discharge from hospital or hospital birth, t  Contaminants were grown 
from 19-5%  of samples collected in the first 48 h after admission and 1 8 1 %  of samples obtained 48 h  or more after 
admission. These proportions did not differ significantly ( p -D l l) .
Table 3: Pathogens causing paediatric bacteraemia in Kilifi District Hospital, 2002-09
bacteraemia and 6 -2%  (1930 of 31 347; 5-9-6-4) in 
patients with no detected episodes of bacteraemia in this 
period. The median interval from sample collection to 
death for patients with nosocomial bacteraernia was 44 It 
(IQR 17-120 h). During the study, 4 -3%  (105 of 2423) of 
all hospital inpatient deaths occurred in patients in whom 
nosocomial bacteraemia was identified.
89 patients developed nosocomial bacteraemia and 
survived to discharge; the median length of hospital stay 
for these patients was 28-9 days (IQR 13 0-41-6). In 
353 matched patients without nosocomial bacteraemia, 
whose hospital stay lasted at least as long as the time 
when bacteraemia developed in the index child, the 
median duration was significantly shorter (18-8 days; 
8-1-30-9; difference between medians 10-1 days, 
p=0 006). Three patients with nosocomial bacteraemia 
were transferred to other facilities, and their eventual 
outcome is unknown.
Gram-negative organisms caused 74% of episodes of 
nosocomial bacteraemia (table 3); Escherichia coli and 
Klebsiella pneumoniae accounted for 21% and 20%  of all 
episodes, respectively. Gram-positive organisms, of 
which Staphylococcus aureus was the most common, 
accounted for 21% of cases. Yeasts accounted for 5%  of 
episodes of nosocomial bloodstream infection. Health­
care-associated (readmission after recent discharge) 
pathogens were much the same as those causing 
community-acquired bacteraemia.
In patients with nosocomial bacteraemia the case- 
fatality rate varied significantly by organism class (x2 test 
p=0-023), being 61% in Gram-negative infections, 38% 
in Gram-positive infections, and 45%  in fungal 
infections. Case-fatality rates were highest in patients 
infected with Acinetobacter spp (74%), Pseudomonas 
aeruginosa (75%), and E coli (77%). We detected no 
evidence of increased mortality in patients with isolates 
considered to be contaminants compared with all other 
patients (x2 test p=0-49).
Discussion
Our large study provides a comprehensive description of 
the epidemiology and microbiological causes of noso­
comial bacteraemia in a representative paediatric service 
in sub-Saharan Africa. With a conventional case 
definition,17 the risk of nosocomial bacteraemia was 
5-9 per 1000 admissions. This finding is consistent with 
a risk of 5-0 per 1000 admissions recorded in a study in 
South Africa in 1989,1K although the cutoff used to 
define infections as nosocomial in that study was 72 h 
after admission rather than 48 h as we used. The risk 
of nosocomial bacteraemia increased significantly 
throughout the study, which could be attributable, in 
part, to increased length of hospital stay in the later years 
of the study. This increase in turn is probably attributable 
to declining numbers of short admissions for malaria1’ 
and an increasing proportion of neonatal admissions. 
These factors suggest that the 2008-09 nosocomial
4
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bacteraemia rate (1-66 per 1000 days in hospital) is a 
better estimate of the present rate in Kilifi District 
Hospital than the study mean (1-00 per 1000 days in 
hospital). The effect o f admission is clear from the fact 
that the incidence of nosocomial bacteraemia was about 
40 times greater than the previously estimated incidence 
of community-acquired bacteraemia.1
Nosocomial bacteraemia is associated with high 
mortality; more than half of all patients (53%) died in 
hospital. Particular pathogens (such as P aeruginosa and 
E coli) were associated with very high case-fatality rates. 
Although other factors might have contributed to the risk 
of both bacteraemia and death, such as nutritional status, 
the case-fatality rate for nosocomial bacteraemia was 
more than double that for community-acquired 
bacteraemia (24%). The interval between detection of 
nosocomial bacteraemia and death (median 44 h) means 
that in many cases bacteraemia could have been the 
cause of death. The crude mortality of paediatric 
nosocomial bacteraemia at 49 hospitals in the USA  
between 1995 and 2001 was 14%.''' At Kilifi District 
Hospital, survivors of nosocomial bacteraemia had a 
substantial morbidity burden, leading to an additional 
10-1 days in hospital per case.
The factor most strongly associated with nosocomial 
bacteraemia in our study was prescription of blood 
transfusion, though this association was confined to 
children who did not have severe anaemia. We assume 
that most children prescribed transfusions at admission 
subsequently received the same, although data were not 
collected on the actual administration of transfusions. 
Overall, 2 %  (52 o f 2573) of transfusion recipients 
subsequently developed nosocomial bacteraemia, which 
is similar to a rate of 3 • 5 %  of post-transfusion bacteraemia 
recorded in Malawi.'" In African hospitals, clinicians 
often use blood transfusions to resuscitate shocked 
patients and for treatment of severe anaemia. In this 
study, 55%  o f patients prescribed a transfusion were 
severely anaemic (1408 of 2573), 27% (689 of 2573) were 
clinically shocked (as per W H O  criteria), and 33% were 
neither severely anaemic nor shocked (847 of 2573). One 
possible explanation for the association of bacteraemia 
with transfusion is that these nosocomial infections 
were, in fact, delayed detection of community-acquired 
septicaemic shock. A  second possible explanation for the 
reported association is contamination of blood for 
transfusion. In a study in Mombasa, Kenya, 8 %  of blood 
packs in the transfusion service had bacterial contamin­
ation." The absence of transfusion-associated risk in 
severely anaemic patients argues against this inter­
pretation. However, the combination of a strong 
association in patients without severe anaemia and local 
evidence of blood contamination supports a critical 
assessment of die role of blood transfusion in nosocomial 
bacteraemia in Africa."
Malnutrition was a risk factor for nosocomial bacter­
aemia at all ages. This finding is consistent with studies
Panel: Research in context 
Systematic review
A  systematic review by WHO in 2010 identified no reports 
about paediatric or adult nosocomial bacteraemia in African 
countries between 1995 and 2008/ We searched PubMed 
using the MeSH terms ("nosocomial" OR "hospital-acquired") 
AND ("bacteraemia" OR "septicaemia") AND (Africa) in 
July, 2011, and found no subsequent studies of relevance.
Interpretation
As far as we are aware, our study is the only recent description 
of hospital-acquired paediatric bacteraemia in sub-Saharan 
Africa, other than outbreak reports. Although this form of 
disease is rare, it has serious effects on morbidity and 
mortality, and the microbiological causes are distinct from 
those of community-acquired bacteraemia. Malnutrition is a 
risk factor for hospital acquired bacteraemia.
of both community-acquired bacteraemia" and late 
hospital mortality in the region/' Other factors previously 
identified as risks for bacteraemia in general are (neonatal) 
age,* H IV  infection, and anaemia/' That H IV  infection 
was not significant in the multivariable model is indicative 
of underascertainment of H IV  status in our study 
population— more than 70%  of patients were o f unknown 
H IV  status because universal H IV  testing was not 
implemented in Kilifi District Hospital until 2008. 
Furthermore, some of the risk o f H IV  infection might 
be indicated through nutritional status. Unexpectedly, 
patients with unknown H IV  status seemed to be at 
decreased risk of disease in the univariable analysis— this 
finding is largely attributable to the confounding effect of 
the time period. Anaemia was not a risk factor after the 
effects of blood transfusion had been incorporated in fire 
model, though, notably, children admitted to Kilifi District 
Hospital are much more anaemic than the general 
population/ No data were available for peripheral intra­
venous catheter use, which is likely to be an important 
risk factor in paediatric nosocomial bacteraemia/'
Our study might have underestimated file true risk of 
nosocomial bacteraemia for two reasons. First, the 
sensitivity of paediatric blood cultures is inherently poor, 
especially when antibiotic use is common and only one 
small-volume culture is collected.1 Second, not all 
children who deteriorate in Kilifi District Hospital are 
investigated with blood cultures. For example, blood for 
culture was obtained during the 48 h  before death from 
less than 50%  of children dying in hospital. Even if only 
10% of these children had had hospital-acquired 
bacteraemia, file calculated risk o f nosocomial bacter­
aemia would have doubled.
We used a standard 48 h cutoff to separate hospital 
and community acquisition, which might have mis- 
dassified some community-acquired infections as 
hospital-acquired. The low sensitivity of blood cultures'
Published online November 30, 2011 D 0l:10 .10 l6 /S0140  6 7 3 6 (l l)6 l6 2 2  X
A rtic le s
could have contributed to this misclassification—some 
community-acquired pathogens might have been missed 
on admission cultures. However, we believe that this 48 h 
threshold is validated, post hoc, by the distribution of 
pathogens isolated. Organisms that are usually acquired 
in the community (such as S pneumoniae) were very 
rarely classified as hospital-acquired in our analysis. 
Organisms such as K pneumoniae, which are typically 
associated with hospital acquisition," were mainly 
classified as nosocomial cases.
Concerns about generalisability naturally arise with 
any single centre study. The risk of paediatric nosocomial 
bacteraemia at Kilifi District Hospital is substantial but it 
is probably even higher in other regional district hospitals. 
Clinical care at Kilifi District Hospital is supported by 
sustained research funding from the Kenya Medical 
Research Institute-Wellcome Trust Research Programme. 
Although the hospital has difficulties o f overcrowding 
and high patient to staff ratios, the clinical services 
(including infection prevention and control) are probably 
o f a higher standard in this institution than in other 
regional facilities.
To what extent are cases of nosocomial bacteraemia 
preventable in a setting such as Kilifi District Hospital? 
The WHO Patient Safety programme2* argues that 
nosocomial disease should never be regarded as an 
unavoidable part of care, even in settings in which funds 
are limited. Indeed, measures to prevent nosocomial 
disease could be some o f the most cost-effective 
interventions in low-income hospital settings." In our 
study, many nosocomial bacteraemia cases occurred in 
easily identifiable high-risk groups o f patients, so the 
efficiency o f  interventions could be increased through 
targeting. Promotion o f hand hygiene, safe blood 
transfusions, and appropriate care of intravascular 
catheters could all greatly reduce the spread o f invasive 
bacterial infections. In Kenya, national guidelines for 
infection prevention and control were published by 
the Ministry of Medical Services in December, 2010;“ 
enforcement o f these basic infection control principles 
could achieve substantial reductions in the burden of 
nosocomial disease.
As far as we are aware, our study is the largest analysis 
o f nosocomial bacteraemia in sub-Saharan Africa (panel) 
and it provides the information base both for future 
research and for immediate efforts to tackle this disease. 
In Kilifi District Hospital, nosocomial bacteraemia occurs 
in six o f every 1000 paediatric inpatients and accounts for 
almost 5% o f deaths in hospital and extended hospital 
stay in survivors. The inherent insensitivity of paediatric 
blood cultures means that these findings are probably 
substantial underestimates. As the major paediatric 
infectious diseases of developing countries are brought 
under control by insecticide-treated bednets, effective 
antimalarial drugs, and vaccines against Haemophilus 
influenzae type b, pneumococcus, and rotavirus, the 
importance of hospital-acquired infections will become
increasingly apparent and an effective response from 
doctors, nurses, hospital managers, and policy makers 
will be essential.
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Wcbappendi\ to paper IV: Background information for Kilifi District Hospital, Kenya
Kilifi District Hospital (KDH) is a Government facility situated in Kilifi town on the Indian Ocean coast of Kenya -  s 
figure 1. The KEMRI-Wellcome Trust Research Programme (KWTRP) was established in 1989 as a collaboration 
between the Kenya Medical Research Institute (KEMRI), the Wellcome Trust and the University of Oxford to conduct 
medical research on infectious diseases of children. During the 1990s, the Programme developed longitudinal clinical 
surveillance in the paediatric wards of KDH. Since 2000, Kilifi Health and Demographic Surveillance System (KHDSS) 
has been established to create a longitudinal community-based cohort study linked, at inception, to hospital morbidity
surveillance by integrating the existing clinical and field-based research infrastructure. Further information about the 
Kilifi HDSS is available at ^ __________
Figure 1: Location of Kilifi District Hospital
The paediatric wards at KDH consist of a 54 bed "general ward”, divided into 5 cubicles, where patients are cohortcd by 
diagnosis, a 9 bed high-dependency unit and a 20 cot newborn unit. The bed occupancy in these units is normally
between 150 and 200%: two children often share a bed/incubator, with an average of 80-90 inpatients, depending on time 
of the year.
There »re normally 6 nurses „„ dury during daytime-shifts and 2 o.emigh, ,in ,he genera, w„ d). T„e ^
pattern applies in the High Dependency Unit in a 3-3-2 shift sverom ri,;u , . ‘ ‘
during ,h= day and via Casual,, a, nigh,. Biood samples are taken by rhe
aide (a el,meal supper, worker who has had phlebotomy lr. inmgl, Thc ^  y
Officer (a junior doctor) or a Clinical Officer (a vocationally-rrained medical professional who uerf • u . 
a junior doctor). During the day, blood cultures are taken to the main KWTRP I h ■ orms simi ar duties to
ihey are taken lo a "satellite- laboralory adjacent to the paediatric ward where a B/iCTEC^  h'"'' h°” ’ 'Vl" 'St *  n'Sht’ 
immediate ¡„eubatiou. ACTEC "“*** 's for
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Paediatric hospital- 
acquired bacteraemia in 
developing countries
Although Alexander Aiken and Aprl|13,joi2 
colleagues (Dec 10, p 2021),* address douo.10 16 5 0 14 0 - 
an important issue, I have a few major 6736(12)60576-5 
concerns about their paper on the 
risk and causes of paediatric hospital- 
acquired bacteraemia.
First I am surprised that Aiken 
and colleagues excluded coagulase- 
negative staphylococci so hastily as a 
contaminant In the developing world, 
such organisms constitute 12%  of all 
Gram-positive organisms that cause 
hospital-acquired infection in neo­
nates, and 17% of those in all age- 
groups.JJ Although often regarded as 
contaminants, coagulase-negative 
staphylococci can cause systemic 
instability resulting in temporary 
cessation of enteral feeding or 
escalation of ventilatory support, and 
are associated with longer hospital 
stay and poorer overall outcome, 
especially in neonates.'1 With the 
growing infrastructure of paediatric 
and neonatal intensive-care units and 
increasing survival o f low birthweight 
babies in developing countries, these 
organisms will definitely become more 
important, as they are in developed 
countries currently.
Second, Aiken and colleagues have Submissions should b« 
calculated weight-for-age 2 scores madevll°u, d«t>onic
. , . , ,  ,  , submission system at
using National Centre for Health [
Statistics (NCHS) reference data. This
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method is fallacious in preterm low- 
birthweight neonates. An intrauterine 
or postnatal growth chart should be 
used until a preterm infant is full-term, 
after which one of the growth charts 
(WHO, NCHS, or US Centers for Disease 
Control and Prevention) should be 
used, corrected for gestational age.5 
This factor is even more important 
in a developing country where 
preterm birth rates are high. Aiken 
and colleagues' lack of attention to 
this point m ight therefore mean that 
the association they found between 
nosocomial bacteraemia and mal­
nutrition, which is more pronounced 
in neonates than in infants and 
children, has been overestimated.
I declare that I have no conflictsof interest
Rashmi Rcmjan Das
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Department of Pediatrics, All India Institute of 
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We congratulate Alexander Aiken and 
colleagues1 on their important study, 
which addresses two under-researched 
areas of hospital epidemiology: 
paediatrics and sub-Saharan Africa. 
The paper brings to light a subtle 
statistical issue that has been largely 
neglected in published studies on 
hospital infection, but which could 
lead to bias when assessing risk factors 
for nosocomial infection 
In survival analyses, as presented by 
Aiken and colleagues, patients who 
do not have bacteraemia are often 
regarded as censored when they are 
discharged. However, hospital discharge 
is a competing event for nosocomial 
infection." Risk factors should then be 
assessed in two ways: an event-specific 
hazard regression (one for nosocomial 
bacteraemia and one for the hospital 
discharge), and a subdistribution 
approach.4 These approaches will 
estimate different effects for risk factors 
than a simple survival analysis if the 
same risk factor has an effect on both 
infection and discharge.5
In the reported survival analysis, 
admission during 2005-09 was 
associated with an increased instant­
aneous risk o f acquiring bacteraemia. 
Accounting for competing events, we 
find that the effect will be even larger 
when length of stay is increasing over 
time (as reported). The difference can 
be explained by the fact that patients 
with an increased length of stay 
acquire bacteraemia more frequently 
than patients with shorter stays (even 
though the infection rates remain the 
same). The figure shows this indirect 
effect with hypothetical values.
Thus, the optimum strategy for 
analysis o f such data would be to treat 
discharge and bacteraemia as com­
peting events.
We declare that we have no conflktsof interest.
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A u th o r s ' reply
Rashmi Das raises the issue of wheth­
er coagulase-negative staphylococci 
could, in some cases, be acting as 
pathogens causing nosocomial 
bacteraemia rather than being 
con tarn i nan ts. We ag ree that, inspecific 
circumstances, coagulase-negative 
staphylococci can act as pathogens, 
most commonly when indwelling 
central vascular access devices are 
used In Intensive-care settings. The 
US Centers for Disease Control and 
Prevention define bacteraemia caused 
by coagulase-negative staphylococci as 
occurring if the patient has symptoms 
or signs of systemic infection, if these 
symptoms or signs are not related to 
Infection elsewhere, and if coagulase- 
negative staphylococci are cultured 
from two or more separate blood 
cultures.1 In Kilifi District Hospital, 
where our study took place, central
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vascular access devices were not in 
use in the study period and there were 
no neonatal or paediatric intensive- 
care facilities. However, it is possible 
that coagulase-negative staphylococci 
could enter through peripheral intra­
venous access. We therefore analysed 
data for children with two or more 
detected episodes o f bacteraemia with 
coagulase-negative staphylococci in 
blood cultures and found no increase 
in either morbidity or mortality above 
baseline. On this basis, we felt it best 
to exclude all coagulase-negative 
staphylococci as likely contaminants, 
although we acknowledge it is possible 
that a small number were acting 
as pathogens.
Dasalso highlights thatcalculation of 
weight-for-ageZ scores with reference 
data from the National Centre for 
Health Statistics is inappropriate 
in preterm neonates, resulting in 
overestimation o f  malnutrition as 
a risk factor for hospital-acquired 
infection in neonates. Preterm birth 
is likely to be an important risk factor 
for nosocomial bacteraemia, and a 
limitation of this study is the inability 
to assess and adjust for it. However, 
determination o f  gestational age 
after delivery on the basis of the date 
of last menstrual period is imprecise 
and antenatal ultrasound dating scans 
were not available in this study.
Martin Wolkewitz and colleagues 
draw attention to the important issue 
o f competing risks in nosocomial 
infections. Essentially, a competing
risks analysis format should be used 
when a mode of exit from an analysis 
cohort is not independent of the 
main outcome— in such a situation, 
the assumption of non-informative 
censoring is not m et
Two events might compete for 
nosocomial bacteraemia in our 
analysis: discharge from hospital 
and inpatient death. With regard 
to discharge, we circumvented this 
problem by defining nosocomial 
bacteraemia as being detected before 
discharge. In reality, some hospital- 
acquired infections only manifest 
after discharge and many of these are 
missed by hospital-based surveillance. 
We agree that in ideal circumstances a 
subdistribution model would providea 
better (and probably higher) estimate 
o f overall disease risk. We note that 
anotherstudy1 found high riskofdeath 
soon after discharge from Kilifi District 
Hospital for malnourished children.
Inpatient death could plausibly bias 
risk-factor estimates in this analysis: 
for example, the risk associated 
with malnutrition might have been 
underestimated, since malnourished 
children are more likely to die (and be 
removed from the at-risk set) during 
inpatient admission. This potential 
bias can be dealt wi th by treati ng death 
as a competing event for nosocomial 
bacteraemia, by use of the stcrreg 
command in STATA (versions lie ), 
giving cause-specific hazard ratios. 
However, this function cannot be done 
for data in which there are multiple
failures per patient, so the analysis 
must be restricted to the first episode 
of nosocomial bacteraemia. If this is 
done for the univariate analysis of the 
nutritional status variable (weight-for­
age Z score), we sec that the parameter 
estimates from Cox regression (as we 
originally used) are reasonable (table). 
For our analysis, we chose to present 
the data incorporating all episodes of 
nosocomial bacteraemia to maximise 
the power of the study, precluding a 
competing events analysis in STATA.
We declare lhatwe have no conflcts of interest.
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C o x  regre ssion C au se -spe d fic  C o x  
regre ssion  w ith  In p a t ie n t  
d e a th  as c o m p e t in g  eve n t
Typesof failure included Multiple failures per patient Single failure per patient
Numbered bacteraemia caves inr luck'd 
Univariable hazard ratio (95* Cl)
212 (original results) 197
Z score >-3 10 10
2 score -3 to -4 206(142-2 99) 205(142-2 95)
1 score <-4 2.52(1-79-3-57) 2 54(181-3-54)
Missing data 3-52(1-20-10-29) 2-72(0 98-7.58)
B o t h  analyses u se  all 331 8 8  adm issions Included In original report.
Table- E ffect o f  t re a t in g  death  a s a c o m p e t in g  ev e n t o n  u n lvarlab le  hazard  ratio  for n u tr it io n a l
s t a t u s  (w e lg h t- fo r -a g e  Z  score)
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ABSTRACT
Background. Methicillin-resistant Staphylococcus aureus (MRSA) is an important 
nosocomial pathogen but little is known about its circulation in hospitals in developing 
countries.
M ethods. We measured the prevalence o f S. aureus and MRSA carriage amongst adult 
inpatients in Thika Hospital, Kenya by means of repeated cross-sectional ward surveys. For 
all S. aureus isolates, we performed antibiotic susceptibility tests, genomic profiling using a 
DNA microarray and spa typing and MLST.
Findings. In this typical mid-sized Kenyan Government hospital, we screened 950 inpatients 
for prevalent carriage o f S. aureus over a four month period. We detected S. aureus carriage 
(either MSSA or MRSA) in 8.9% (85/950; 95%CI 7.1-10.8) o f hospital inpatients. MRSA 
carriage was relatively rare amongst hospital inpatients -  only 7.0% (6/86; 95%CI 1.5- 
12.5%) of all S. aureus isolates were MRSA. Most MRSA (5/6) were obtained from bums 
patients with prolonged admissions, who only represented a small proportion o f the inpatient 
population. All MRSA strains were o f the same clone (MLST ST239; spa type t037) with 
concurrent resistance to multiple antibiotic classes. MSSA isolates were diverse and rarely 
expressed antibiotic resistance except against benzyl-penicillin and co-trimoxazole.
In terpreta tion . Although carriage rates for S. aureus and the MRSA prevalence in this 
Kenyan hospital were both low, bums patient were identified as a high risk group for 
carriage. The high frequency o f genetically indistinguishable isolates suggests that there was 
local transmission o f both MRSA and MSSA carriage.
Keywords: Staphylococcus aureus-, MRSA; Kenya; hospitals; carriage prevalence
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INTRODUCTION
Staphylococcus aureus is both a human commensal and an important pathogen (1). 
Methicillin-resistant S. aureus (MRS A) is a common cause o f healthcare-associated 
infections in both developed and developing countries, though limited information is 
available from the latter (2). In hospital wards in developing countries, the risk o f nosocomial 
transmission is likely to be high due to close physical proximity o f patients, inadequate 
staffing, unreliable water-supply for handwashing, lack o f alcohol hand-rub, isolation 
facilities or expertise for infection control (3) - these could represent near-ideal conditions for 
nosocomial circulation o f drug-resistant bacteria. In sub-Saharan Africa, screening for MRSA 
carriage during hospital admission is rarely considered a healthcare priority and is 
infrequently performed, so patients carrying MRSA in hospitals in this region are unlikely to 
be identified or isolated.
Carriage o f  5. aureus is most commonly detected in the anterior nares (nostrils), though other 
sites on the body are frequently colonised, most commonly the groin and the axillae (1). 
Isolates from the nares are normally indistinguishable by molecular typing from those found 
on other body sites (4). Most 5. aureus infections originate from self-carried strains, although 
disease only develops in a small minority o f carriers (4-5). Cross sectional studies in adult 
populations have found nasal carriage rates o f  around 25%, although much o f this work has 
been conducted in high-income settings (1). Carriage o f 5*. aureus (either MRSA or 
methicillin-sensitive S. aureus (MSSA)) often lasts from months to years, and tends to be 
longer amongst individuals with chronic skin disease (6).
MRSA expresses resistance to all /3-lactam antibiotics (penicillins, cephalosporins, 
carbapenems) by producing a penicillin-binding protein (PBP2a) from the mecA gene in the 
staphylococcal cassette chromosome (SCCmec). MRSA was first described in 1961 in the 
UK, very soon after the introduction o f anti-staphylococcal penicillins (7). Some of the 
earliest reports o f MRSA in sub-Saharan African came from various Kenyan Hospitals 
(including Thika Hospital) in the early 1990’s, where it was principally found amongst bums 
patients (8). The prevalence o f MRSA is the percentage o f a collection o f S.aureus isolates 
expressing resistance to methicillin -  a marker for the presence o f mecA. This has been 
estimated in a small number o f studies in sub-Saharan Africa over the past 20 years, mostly 
based on clinical (disease-causing) isolates obtained at university teaching hospitals in major 
cities -  see table 1. These studies have shown considerable variation: a relatively high
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microbiological prevalence was found in clinical isolates in Ibadan, Nigeria in 2006-7 (9 ), 
but no MRSA was found amongst 45 S. aureus carriage isolates from healthcare workers in a 
large private hospital in Nairobi, Kenya in 2010 (10). Much more information about the 
nature o f MRSA strains in circulation is available in South Africa (11), but data from this 
country is unlikely to be regionally representative. We are not aware o f any previous 
estimates o f  the carriage rate o f MRSA or S. aureus for an inpatient population in sub-Saharan 
Africa outside o f South Africa. Most MRSA strains in Africa appear to derive from a small 
number o f common ancestors: a recent study examining 86 MRSA isolates from five 
hospitals in West Africa and Madagascar found that 88% of these isolates were from one of 
three clonal strains (12). By contrast, there was wide diversity amongst MSSA clones from 
the same institutions (13). No similar studies have been reported from East Africa. The types 
o f MRSA circulating in East Africa are unknown.
We aimed to describe the prevalence and diversity o f MSSA and MRSA carriage amongst 
inpatients in a typical mid-sized public-service hospital in Kenya.
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MATERIALS AND METHODS
Study setting and patient procedures: Thika Level 5 Hospital is a 300-bed Government 
Hospital in the town o f Thika, approximately 50km north-east o f Nairobi, in Central 
Province, Kenya. It provides medical, surgical, gynaecological, obstetric and paediatric 
services to a mixed urban and rural population and has a total of seven inpatient wards. 
Throughout this study there was no full-time infection control nurse in Thika Hospital, 
though a Hospital Infection Prevention and Control Committee met monthly. Daily bed 
occupancy rates in adult wards in 2011 were typically between 120 and 140% and all patients 
were nursed in communal bays.
Between the 11th July and 7th November 2011, all patients in adult inpatient medical, surgical 
and gynaecological wards were screened on alternate weeks for carriage o f S. aureus. Any 
patients who stayed in the ward overnight prior to screening were eligible for inclusion, 
provided that they (or a family member) were able to give consent. The surgical wards 
included some paediatric patients receiving treatment for surgical conditions, who were also 
included in screening. Patients who were MRSA-negative were repeatedly screened 
throughout their entire period o f hospitalisation. Results regarding MRS A carriage were 
relayed to patients and clinicians as soon as these became available. Patients found to have 
carriage o f MRSA were subsequently treated with vancomycin if  an infection with S. aureus 
was suspected. Patient data were collected from patient notes or by direct interview during 
screening and single-entered into a local database. Statistical analysis was carried out using 
STATA v l2  (StataCorp, College Station, Texas, USA).
Ethics statement: This study was approved by the Kenya Medical Research Institute 
(KEMRI) National Ethical Review Committee. All patients (or their relatives) gave written 
informed consent to nasal and skin swab collection.
Swab processing: Paired nasal and axillary skin swabs were collected from each patient and 
were immediately transferred to Mannitol Salt broth (HiMedia Laboratories, Mumbai, India) 
for overnight selective enrichment. The following day, aliquots were plated onto Blood Agar 
(BA) media. Single colonies from plates which showed suspected S. aureus colony growth, 
were further processed by Gram stain, catalase and coagulase test, and checked for the ability 
to hydrolyse DNA. Disc diffusion tests with cefoxitin (lOpg) were used to identify suspected 
MRSA according to British Society for Antimicrobial Chemotherapy guidelines.
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All media were locally prepared and batch controlled using appropriate internal quality 
control strains (S. aureus ATCC 25923, S. epidermidis ATCC 12228, E. coli ATCC 25922). 
Isolates were initially kept at -20°C and then transferred to -80°C for storage. Isolates were 
shipped to the University Medical Centre Groningen for further investigations.
Antimicrobial susceptibility testing. Susceptibility to a standard panel o f  antibiotics 
plus chloramphenicol was performed using the automated Vitek 2 system (bioMerieux, 
Marcy l’Etoile, France). The results were interpreted in accordance with the 2012 guidelines 
o f the Clinical and Laboratory Standards Institute. Isolates positive for inducible clindamycin 
resistance were assumed to be resistant to Iincosamines and macrolides.
Extraction of genomic DNA. Total DNA was prepared from a loop o f S. aureus cells 
lifted from blood agar plates and transferred to 2-ml tubes containing 500pl o f  water and 
zirconia/silica beads. The tubes were fixed in a TissueLyser homogenizer (Qiagen, Venlo, 
Netherlands) and the cells were disrupted by vortexing for 5min at 30Hz. The suspensions 
were clarified by centrifugation (14,000 rpm for lOmin), and the supernatant was used for 
DNA extraction with the DNeasy Blood & Tissue kit (Qiagen) according to the 
manufacturer's protocol. The DNA concentration was quantified using a NanoDrop 
spectrophotometer (NanoDrop Technologies, Wilmington, DE) at 260nm.
Genotyping. Spa typing (14) and Multi Locus Sequence Typing (MLST) (15) were 
performed as described previously. Spa types were assigned by Ridom StaphType software 
version 1.4.6 (Ridom GmbH, Wurzburg, Germany) and the Ridom SpaServer 
(http://www.spaserver.ridom.de) (16) after adhering to the SeqNet.org quality procedure (17). 
Sequences o f each MLST locus were compared to the data in the S. aureus MLST database 
(http://saureus.mlst.net/), and resulting allelic profiles were assigned to particular sequence 
types (STs) for each isolate. eBURST software (v3, http://eburst.mlst.net) was used to 
classify related Sequence Types (STs) into clonal complexes (CCs) A singleton was defined 
as a sequence type that did not group with any clonal complex. The diagnostic DNA 
microarrays (StaphyType; Alere Technologies, Jena, Germany) and StaphyType DNA 
microarray kit were used for study o f the presence o f genes encoding species markers, agr 
types and virulence factors as described previously (18).
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RESULTS 
Carriage of S . aureus
A total o f  950 screening swabs were obtained from inpatients in the medical, surgical and 
gynaecological wards o f Thika Hospital. Patients ranged in age between 1 and 90 years and 
52% were male. A total o f  85 patients (85/950; 8.9%; 95%Cl 7.1-10.8) were found to carry S. 
aureus. One patient had two distinct S. aureus strains (one MRSA and one MSSA). Thus, a 
total o f 86 S. aureus isolates were collected. Species identification was confirmed by the 
presence o f the S.aureus-specific genes (spa, coA, nucl) and mecA for MRSA. We found no 
association between carriage of S. aureus and either age group or sex (x2test; p>0.1).
Among the S. aureus isolates obtained, six (6/86; 7.0%; 95%CI 1.5-12.5%) were MRSA. All 
o f these were obtained from surgical patients, comprising three adult men and one male child 
(male surgical ward) and one woman and one female child (female surgical ward). All o f  
these patients had been hospitalised for a prolonged period, five with extensive bums and one 
with a fractured femur. The median admission length prior to MRSA detection was 27 days 
(range 25 - 172 days).
Antibiotic resistance
All six MRSA isolates were co-resistant to gentamicin, ciprofloxacin, tetracycline and co- 
trimoxazole and five were also resistant to lincosamine and macrolide antibiotics. All MRSA 
isolates were susceptible to chloramphenicol, vancomycin and mupirocin. Amongst the 
MSSA isolates obtained, resistance to penicillin, tetracycline and SXT was common, but not 
to any other antibiotics -  see table 2.
Diversity of isolates established by spa  typing and MLST analyses
The 86 S. aureus isolates were assigned to 29 spa types, ranging in length between four 
(tl0499) and 12 (t005) repeats. Two new repeats, r558 and r559, and five new spa types, 
tl0496, tl0497, tl0498, tl0499 and tl0960, were found and assigned over the course o f this 
study. Sixteen spa types were represented by 2 or more isolates (73 isolates in total), while 13 
spa types contained a single isolate. All six MRSA isolates identified were o f  spa type t037. 
Among the MSSA isolates, t223 (n = 15) was the most frequent spa type, followed by t064 (n 
= 10) and tl31 (n = 10). Other spa types (n = 25) were represented by four or less MSSA 
isolates.
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A single representative o f each spa type was analyzed by MLST. Twenty STs were identified. 
Five new MLST allelic profiles and three new STs were found; the latter were assigned as 
ST2429, ST2430, and ST2431. All six MRSA isolates belonged to international clone ST239. 
The correspondence between MLST and spa typing is shown in table 3.
Using eBURSTv3, all MLST STs obtained in the study were assigned to CCs. This method 
identified ST2430 as a single locus variant o f CC121; the remaining 18 STs were unrelated. 
Subsequently, MLST data obtained in this study were compared to the S. aureus MLST 
database. O f the 68 isolates which were grouped into 14 CCs, the majority o f these (64/68, 
94%) had a founder sequence type -  see Table 3.
Microarrays
The distribution of genes of the core variable genome and the identification o f the allelic 
variants o f genes o f the core genome varied between MLST sequence type -  full details o f 
these results including profiles for all MSSA isolates are given as supplementary material in 
appendix SI.
All six MRSA isolates carried the SCCmec III element, the mercury resistance operon, ccrC, 
the virulence genes sek and seq, the protease splA, splB and splE genes but phage-associated 
genes sak, sen and chp were present only in four isolates. Five isolates carried the haemolysins 
genes, hla and hlb. All isolates had the same set o f the MSCRAMM genes (bbp, cna, ebh,fib, 
fnbA,fnbB, map, sdrC, sdrD, and sasG).
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DISCUSSION
In this typical mid-sized Kenyan government hospital, carriage o f  S. aureus amongst 
inpatients was found to be relatively infrequent (8.9%; 95%CI 7.1-10.8). MRSA constituted 
only 6.9% (95%CI 1.5-12.5%) of all S. aureus isolates obtained. Both o f these results were 
surprisingly low, given that nasal carriage o f S. aureus in the general population is typically 
thought to be around 25% (1) and the crowded conditions in Thika Hospital should lead to 
frequent transmission o f MRSA. The small number o f MRSA isolates obtained leaves us with 
a wide confidence interval for the true microbiological prevalence.
Almost all MRSA carriage was confined to patients with bums who constituted 
approximately 10% o f adult inpatients admitted to the surgical wards and approximately 5% 
o f inpatients overall. In sub-Saharan Africa, prolonged hospital admission after bums injuries 
are common (19), and as specialist bums units are rarely available, these patients often make 
up a sizeable proportion o f the general inpatient population. Bums patients are at increased 
risk o f  invasive bacterial disease (20) and hence colonisation o f these patients with a multi­
drug resistance organism is o f  particular concern. Chloramphenicol is a widely used 2nd line 
antibiotic in sub-Saharan Africa and as all isolates in Thika Hospital were found to be 
susceptible to this drug, this might be a suitable empirical alternative to vancomycin for 
suspected MRSA infections in this setting.
These Thika MRSA isolates belong to the widespread ST239 strain, formerly known as the 
Hungarian/Brazilian epidemic strain which is typically associated with hospital-acquisition. 
This has been documented to occur in sub-Saharan Africa in Senegal, Niger (12), South 
Africa (11) and was noted to be common amongst hospitalised bums patients in Nigeria (9). 
The pattern o f multi-class antibiotic resistance that we found in Thika Hospital is typical of 
this strain in African settings (12). A recent study described the intercontinental transmission 
o f this strain from Europe to Asia and the Americas, but did not include any African isolates 
(21).
When designing this study, we expected the prevalence o f S. aureus and MRSA to be 
considerably higher than we actually found. The only previous study o f MRSA carriage in 
hospital inpatients in sub-Saharan Africa was conducted in TB patients hospitalised in 
KwaZulu-Natal in South Africa (22) where MRSA carriage was found to be 21% on 
admission. Many o f these MRSA colonised patients had recent hospitalisations and advanced
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HIV disease, which may have contributed to the high carriage prevalence. In this study, a 
standard cross-sectional approach for detecting carriage was used, but this may have missed 
some cases o f nosocomial acquisition occurring late in admission, which could have been 
detected by additional screening on discharge.
The reason for the surprisingly low overall rate o f 5. aureus carriage (8.9%) in our study is 
unclear. We feel that is it unlikely that procedural errors with swab collection could account 
for this -  all swab collection was supervised in person and regularly quality controlled by one 
investigator (AA) and an experienced researcher (HG) made an on-site review o f the 
collection and processing methods in the first month o f the study. Genetic differences could 
provide an explanation for this low carriage rate -  human genetic factors are thought to be 
important determinants for persistent colonisation with & aureus (23). In the USA, one study 
found people o f African ethnicity to have low 5. aureus carriage rates (3/9 individuals) in 
comparison to White non-Hispanic (27/50) or Hispanic (8/20) individuals (24). It is also 
possible that carriage o f coagulase-negative staphylococci (CoNS) or other members o f the 
human skin microbiota may have been competitively inhibiting £  aureus colonisation, as has 
recently been demonstrated in animal models (25) -  but our study did not set out to examine 
this possibility.
Many o f the spa types (17%; 5/29) and MLST profiles (15%, 3/20) identified in this 
population were novel. This reflects the fact that very few African sites have previously 
contributed typing information to the relevant databases. The lack o f diversity amongst the 
MRSA and MSSA isolates obtained in our institution over a four month period suggests that 
these were probably being transmitted by local (i.e. within-hospital) routes rather than 
repeated introduction from external sources, though without greater knowledge o f the 
diversity o f strains circulating in Kenya or East Africa as a whole, we cannot be certain o f  
this. Due to overcrowding, lack o f isolation facilities and awareness o f the problem, 
eliminating nosocomial transmission of organisms such as MRSA in institutions like Thika 
Hospital will be challenging.
CONCLUSION
Antibiotic resistance is a growing concern in developing countries (26) and local studies are 
needed to understand the transmission o f drug-resistant organisms and guide strategies for
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containment (27). MRSA is an important nosocomial pathogen in developed countries but 
little is known about it in sub-Saharan Africa. This is the largest study examining prevalent 
inpatient carriage of S. aureus in sub-Saharan Africa and it was conducted in a typical mid­
sized Kenyan Government Hospital. Most o f the existing studies o f MRSA in Africa have 
examined clinical isolates in large hospitals in major cities and these are unlikely to be 
representative o f hospitals in the region. We found inpatient carriage o f MRSA to be 
relatively infrequent and was mainly confined to patients with bums. The lack o f genetic 
diversity o f these isolates obtained suggests “within-hospital” transmission. The multiple 
drug resistance o f the MRSA found in Thika hospital coupled with the vulnerability o f bums 
patients to invasive bacterial infection is a cause for concern. Thika Hospital faces many 
infection control challenges that are typical o f those encountered in African healthcare 
facilities. Much work is needed in Kenya and throughout the region to formulate national and 
local policies on appropriate Infection Prevention and Control (28) to tackle issues such as 
MRSA and, more importantly, to put these into effect practice.
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Table 1 -  Estimates of microbiological prevalence of MRSA in sub-Saharan Africa
Study location Year(s) Isolates from Number of 
MRS MS.aureus
MRSA %
Lagos, Nigeria (29) 1996-7 Clinical specimens 42/142 29.6
Nairobi, Kenya (29) 1996-7 Clinical specimens 38/137 27.7
Yaounde, Cameroon (29) 1996-7 Clinical specimens 27/127 21.3
Abidjan, Cote d ’Ivoire (29) 1996-7 Clinical specimens 26/155 16.8
Dakar, Senegal (29) 1996-7 Clinical specimens 21/168 12.5
KwaZulu-Natal Province, 
South Africa (30)
2001-3 Clinical specimens 61/227 26.9
Ibadan, Nigeria (9) 2006-7 Clinical + carriage specimens 70/346 20.2
5 major cities in Africa* (12) 2007-8 Clinical specimens 86/555 15.5
Nairobi, Kenya (10) 2010
HCW nasal carriage 
specimens-!- 0/45 0.0
* Data from hospitals in capital or largest cities of Senegal, Morocco, Niger, Cameroon, 
Madagascar.
t  HCW = Health Care Workers
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Table 2 -  Overall sensitivity patterns of MRSA and MSSA carriage isolates from Thika Hospital
I Antibiotic Proportion susceptible (%)
MSSA (n=80) MRSA (n=6)
Cefoxitin 100 0
Benzylpenicillin 26 0
Co-trimoxazole 60 0
Tetracycline 85 0
Gentamicin 99 0
Ciprofloxacin 100 0
Erythromicin / Clindamycin 99 17
Rifampicin 99 83
Chloramphenicol 100 100
Vancomycin 100 100
Mupirocin 100 100
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Table 3 -MLST and spa types from 86 S. a u re u s  isolates obtained at Thika Hospital, Kenya
MLST CC* ST within CC 
(number of isolates)
spa types
(number of isolates, if >1 spa type)
CC22 ST22 (17) t223 (15), t005 (1), tl 0498 (1)
CC8 ST8 (14) t064 (10), tl21 (3), 110497 (1)
ST2430 (4) t645
CC121 ST121 (3) t314
CC239 ST239 (6) t037
CC97 ST97 (5) t359 (2), t l 965 (2), t267 (l)
CC5 ST5 (3) t002
CC30 ST30 (3) t318 (2), tl 130 (1)
CC7 ST7 (3) t091
CC6 ST6 (2) t701
CC15 ST 15 (2) t084 ( 1 ), t491 (1)
CC 25 ST25 (2) t3772
CC72 ST72 (2) t Ì 48 ( 1 ), t4353 (1)
CC1 STI (1) tl 27
CC45 ST45 (1) tO 15
ST 1290 (10) tl 31
ST 152 (4) t355
singletons ST2431 (2) t 10496
ST2019 (1) t10499
ST2429 (1) t 10960
* = Clonal Complex nomenclature derived from MLST database.
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APPENDIX 1: SUPPLEMENTARY MATERIAL.
This section describes full microarray results from the MSSA isolates from Thika Hospital.
Factors present in all isolates were as follows: virulence genes hid, sspA and sspB encoding 
hemolysin delta, serine protease V8 and cysteine protease, respectively; immune evasion 
gene isaB encoding immunodominant antigen B; adhesion factors genes clfA, dfB, eno, ehpS 
and vwb encoding clumping factor A, clumping factor B, enolase, cell wall associated 
fibronectin-binding protein and von Willebrand factor, respectively; the intercellular adhesion 
locus (ica) responsible for biofilm production, however only the icaA gene from this locus 
was present in all isolates.
ST22-MSSA
All isolates carried the enterotoxin gene cluster egc (seg, sei, sem, sen, seo, and sen) and 
almost all, with the exception o f a single isolate with the spa type t005, were positive for the 
gene encoding the toxic shock syndrome toxin (tstl). All isolates were characterized by the 
lack o f the protease genes splA, splB and splE but contained (3-haemolysin-converting phages 
(sak, chp and sen), however, in 2 isolates only sak was detected. The hla and hlh genes 
encoding alpha- and beta-hemolysins, respectively, were found in all isolates with the 
exception o f a single isolate in which the hla gene was absent. In all isolates the 
MSCRAMMs genes such as cna,fib, sdrC and sasG were present, while carriage o f the bbp, 
fnbA ,fnbB, map, and sdrD genes was variable.
ST8-MSSA
The majority o f  isolates (12 out o f 14) from this group possessed the enterotoxin profile 
(sea+seb+sek+seq) characteristic for the strain of CC8-MRSA-IV which is known as 
USA500. Moreover, one o f the MSSA USA500 isolates possessed the tstl gene. Two 
remaining isolates from this group were equipped with the sea gene, and one of them 
additionally had the sek gene. All ST8-MSSA isolates from Thika Hospital showed 
homogenous distribution of the hemolysins genes (hla and hlb, with the exception o f a single 
isolate in which the hla gene was not detected), immune evasion genes (sak, sen, splA, 
splB,and splE), and the MSCRAMMs genes (bbp, ebh,fib,fnbA,fnbB, map, sdrC, sdrD, and 
sasG).
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ST 1290-MSS A
The enterotoxin genes were not detected in this group but majority o f  the isolates (6 out o f 
10) harboured the exfoliative toxin gene eta. All isolates had either the hla or hlb gene. The 
immune evasion genes sak, sen. splA, splB, and splE were found in all isolates and a single 
isolate had additionally the chp gene. The MSCRAMMs profile bbp+ebh+fib+fnbA +fnbB+ 
sdrC+sdrD+sasG was found in all isolates, while the map gene was additionally found in 
seven isolates.
CC121-MSSA
All isolates carried the bi-component toxin Panton-Valentine leukocidin (PVL) genes and 
carried seb, sec, and the egc enterotoxin locus (seg, sei, sent, sen, seo, and sea). The hla and 
Mb genes coding for hemolysins alpha and beta were found in all isolates o f this clonal 
complex. The genes associated with beta-haemolysin converting phages such as sak and sen 
were present, while chp was absent in all CC121 MSSA isolates. The distribution o f the 
protease genes in this clonal complex was sequence type specific. The isolates o f ST2430 
possessed the splA and splB genes, whereas the isolates o f  STI21 had only the splB gene. All 
isolates had the MSCRAMMs genes as follows: bbp, cna, ebh,fnbA,fnbB, map, sdrC, and 
sdrD. Moreover, 4 out of 7 isolates possessed additional adhesion gene encoding the S  
aureus surface protein G (SasG), and this distribution was not ST specific.
ST97-MSSA
This group o f isolates was characterized by the lack o f the toxin genes. All other groups o f 
genes were homogeneously distributed among the isolates: hemolysins (hla and Mb), immune 
evasion (sak, sen, splA, splB, and splE) and MSCRAMMs (bbp, ebh,fib,fnbA,fnbB, map, 
sdrC, sdrD, and sasG)
ST 152-MSS A
All isolates were PVL-positive and enterotoxins-negative. The only toxin detected was EdinB 
which structural gene was present among 3 out of 4 isolates. Two isolates possessed the hla 
and hlb genes, one had the hla gene and one isolate had neither hla nor hlb. The protease 
genes splA, splB and splE were not detected in all isolates. Two MSCRAMMs profiles 
bbp+can+ebh+fnbA+fnbB+sdrD and bbp+can+ebh+fnbA+fnbB+sdrD+sasG, were equally 
found in ST152 MSSA isolates.
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ST7-MSSA
The sea gene was detected in all three isolates from this group. Moreover, one of the ST7 
isolates was positive for the sed gene. All isolates had the same hemolysin and immune 
evasion gene profiles {hla, hlb and sak, sen, splA, splB, splE, respectively). Almost all 
isolates had the same MSCRAMM gene profile (bbp+ebh+fib+fnbA+fnbB+map+sdrC+sdrD) 
and the only difference was found for a single isolate which possessed additionally the sasG 
gene.
ST5-MSSA
All three isolates shared the same hemolysin and immune evasion gene content {hla, hlb, sak, 
chp, sen, splA, and splB). Two isolates showed the same distribution o f superantigens (seb, 
sek, seq, and the cluster egc) and MSCRAMMs (bbp, ebh,fib,fnbA,fnbB, map, sdrC, sdrD, 
and sasG). Third isolate harbored the enterotoxin gene cluster egc and almost the same 
MSCRAMM genes with the exception o f sdrD which was not detected in the genome.
ST30-MSSA
All 3 isolates had the same content for genes encoding hemolysins {hla and hlb) immune 
evasion {sak, chp, sen, splE) and superantigens {egc cluster: seg, set, sem, sen, seo, and seu). 
Moreover, all isolates were characterized by the presence o f  genes encoding PVL. The only 
difference between isolates was in the MSCRAMM content: two isolates possessed the bbp, 
cna, ebh,fib,fnbA,fnbB, map, sdrC and sdrD genes. The third isolate had almost the same 
MSCRAMM gene content like two other isolates with the exception of the/nbfi gene which 
was not detected in the genomic DNA.
ST2431-MSSA
Two isolates o f this group did not have any toxin gene. They shared the same immune 
evasion genes, sak and sen, but differed in the content of the hemolysin {hla+/ hlb+ and hla+1 
hlb-) and MSCRAMM {bbp, ebh,fnbA,fnbB, sdrC, sdrD and the same content plus sasG) 
genes.
ST6-MSSA
Both isolates shared exactly the same gene content. They showed the gene content as follows:
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hla, hlb, sak, sen, splA, sp/B, splE, 
sasG.
sea, bbp, cna, ebh, fib , fnbA, fnbB , map, sdrC, sdrD, and
ST72-MSSA
This group was composed o f 2 isolates with different spa types. The isolates shared the same 
hemolysin (hla and hlb), immune evasion (safe,sen,splA,splB,splE) and MSCRAMM (bbp, 
ebh, fib , fnbA, fnbB, map, sdrC, sdrD, and sasG) genes but differed substantially in the 
content o f the superantigen genes. One o f the isolates (with the spa type tl48) harbored the
enterotoxin egc genes, while second one (with the spa type t4353) possessed the egc cluster 
and also the tstl, sec, sel genes.
ST15-MSSA
Both isolates were characterized by the presence of the same gene content and they did not 
have any toxin genes. They yielded hybridisation signals for the hemolysin gene hla, immune 
evasion genes chp, sen, splA, splB, splE, and the MSCRAMM genes bbp, ebh, fib, fnbA 
fnbB, map, sdrC, sdrD, sasG.
ST25-MSSA
Two isolates showed almost the same gene content. The exceptional situation was found for 
the hemolysin genes. One isolate had both the hla and hlb genes, while in genomic DNA of 
second isolate these genes were not detected. The immune evasion 
(sak,chp,sen,splA,splB,splE), superantigen (sec, sel, and the egc cluster) and MSCRAMM 
(bbp, ebh, fib , fnbA, fnbB, map, sdrC, sdrD) genes were the same in both isolates. The very 
characteristic feature o f the isolates from this group was the presence o f the etc/gene coding 
for exfoliative toxin D. This gene was not found in other isolates in this collection. Another 
exfoliative toxin gene detected in the ST25 isolates was edinB.
ST2429-MSSA
The one isolate o f this group did not show any hybridization signal for the toxin genes. It 
revealed hybridization signals for: the hla gene; phage-associated genes sak, sen and chp; 
protease genes splA and splE; and the adhesion genes cna, ebh, fib, fnbA, fnbB, sdrC and 
sasG.
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ST2019-MSS A
The one isolate did not have genes for enterotoxins and exfoliative toxins. However, the PVL 
genes were detected in its genomic DNA. The isolate possessed the hla and hlb genes for 
hemolysins alpha and beta, respectively. Immune evasion genes genes chp and sen were 
present, whereas sak and protease splA, splB and splE genes were absent. The MSCRAMM 
genes bbp, ebhJnbAJnbB, sdrC, and sdrD were detected in this isolate.
ST1-MSSA
Genomic content o f  the MSSA ST1 representative showed the presence of the superantigen 
sea, seh, sek, and seq genes. The hybridization results also revealed that this isolate harbored 
the PVL genes, the hemolysin genes hla and hlb, immune evasion genes sak, sen, splA, splB, 
splE, and the MSCRAMM genes bbp, cna, ebh,fib,fnbA,fnbB, sdrC, sdrD, sasG.
ST45-MSSA
The only isolate of this group possessed the genes encoding enterotoxins seb and that o f  the 
e&  cIuster (se& seb sem, sen, seo, and seu). Moreover, it revealed hybridization signals for 
the hemolysins alpha and beta genes (hla and hlb) and phage-associated genes sak, sen and 
chp. Protease genes splA, splB and splE were not detected. The adhesion genes detected in 
the genomic DNA were as follow: bbp, cna, ebh,fib,fnbA,fnbB, map, sdrCznd sdrD.
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Chapter 7. Discussion and conclusion
This final chapter draws together all the different strands o f nosocomial infection research 
that I have undertaken in the course o f  this thesis. I have done this by looking at a series o f 
issues or questions that arise from my work and exploring how each o f the three main project 
areas (SSI, nosocomial bacteraemia and MRSA) has contributed to my thoughts on the topic.
I also have tried to highlight some o f the interesting contrasts between these projects and how 
this body o f  work, as a whole, points towards the future.
7.1. P rev ious nosocom ial infection re sea rch  in A frica  -  o r  lack  (h e reo f
As we have seen, historically, there has been very little research into most forms of 
hospital-acquired infection in developing countries -  but some progress is now being made.
In Kenya, as in most African countries, research in Infection Control has had to compete for 
funding and attention with a wide range o f other pressing, and often more high-profile, public 
health problems. But the dearth o f  research is also, in part, due to an intellectual impasse -  
without original work, the scale o f the problem and the potential benefits remain largely 
unknown and hence new researchers are not attracted into the area and no new work is 
undertaken. All three research areas in this thesis made reference to the two recent systematic 
reviews by the WHO Patient Safety Group on nosocomial infections in developing countries 
- 1 think these reviews will represent a turning point in attention devoted to this topic. The 
coverage o f these WHO reviews was by no means exhaustive - the systematic review o f SSI 
interventions in Africa was an attempt to address one notable omission - but given the huge 
breadth o f topics that they did cover, these reviews provided a useful starting-point for all the 
different components o f my own work and will probably continue to serve the same purpose 
for many others in diverse areas of nosocomial infection research for many years to come.
Although much o f the existing research in hospital-acquired infections in Africa has been 
in the form o f burden-of-disease studies, I think these will continue to be important for some 
time to come -  as many Infection Control professionals are fond o f  quoting: “If  you cannot 
measure it, you cannot improve it.” There were no African publications identified in the 
WHO systematic review for health-care associated pneumonia and only one for urinary tract 
infections -  these are important forms o f disease that need a better understanding in the 
context o f  African hospitals. In the future, wider adoption o f more advanced medical 
technologies in African healthcare systems (e.g. kidney dialysis, chemotherapy, radiotherapy,
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Intensive Care Units) and progressively increasing numbers o f patients on long-term Anti- 
Retroviral Therapy for HIV will produce an expanding population of immunocompromised 
individuals requiring frequent hospitalisations -  these patients will be extremely vulnerable to 
various types o f  hospital-acquired infections.
The lack o f background research in this field has given me both opportunities and 
challenges. Despite their various limitations, all three projects that I undertook were 
respectively the “largest-ever” studies o f their particular type in sub-Saharan Africa, which 
gave me a unique position from which to make original observations on each o f these topics. 
When working on nosocomial bacteraemia, I was able, to some extent, to create a new set o f 
definitions for “nosocomial”, “healthcare-associated” and “community-acquired” infections, 
which may prove useful for enabling future comparative work in this field. Conversely, the ' 
challenge o f researching in such unexplored territory was that little could be learned from the 
previous work o f others and many of the trial-and-error processes that I engaged in concerned 
quite elementary research questions. For example, the issue o f how to follow-up a patient for 
30 days after their surgery seems basic, but it took much fruitless attendance at outpatient 
clinics to conclude that telephone calls might be a more profitable approach to this question.
A more fundamental study limitation arose when my projected sample size for the S. aureus 
carriage study substantially overestimated the likely prevalence of both MSSA and MRSA 
carriage -  neither the estimates obtained from other African research nor those from high- 
income countries were in line with the ultimate results. This meant that a study originally 
planned as a case-control and modelling project ultimately evolved into quite a different 
format.
7.2. M ethodolog ica l challenges -  lim ita tions o f  su rveillance
Two o f the three projects that I worked on (SSI and nosocomial bacteraemia) revolved 
around the use o f surveillance data for measuring the burden o f HAI, whereas the MRSA 
project set out from the beginning to measure prevalence as a pure research exercise. Over 
the period o f conducting SSI surveillance at Thika Hospital, I found these to be a difficult 
outcome measure to work with as an epidemiologist essentially because o f the lack o f an 
entirely objective diagnostic method. This subjectivity means that continuous effort must be 
devoted to ensuring the reliability o f observations within and between observers -  although 
within a single institution a practical way to achieve this was by having close oversight o f all 
diagnoses by a single individual. In larger-scale research or multi-site surveillance it would 
obviously be impossible to achieve this -  the difficulty of standardising a subjective
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diagnosis between individuals would then become considerable. A second difficulty of 
working with SSI is the extreme heterogeneity of the different forms of SSI -  superficial 
SSIs, whilst common, are usually no more than a minor inconvenience whilst organ-space 
SSI are likely to be life-threatening but occur rarely -  to consider these as comparable events 
is illogical. The obvious solution to this issue is to stratify the single entity of SSI into various 
subtypes -  adherence to the standard diagnostic definition of the CDC-NHNS also gives a 
sensible sub-classification system.
A major limitation of HAI surveillance systems is that these are an imperfect tool for 
assessing the impact of an Infection Control intervention. This is because all forms of HAI 
surveillance system are particularly vulnerable to what I call a “surveillance-effort paradox" 
This paradox is that the more effort that is made to perform comprehensive HAI surveillance, 
the higher the apparent rate of infection and the more extensive the disease appears to be
essentially, the old adage “the harder you 
look, the more you find”. Conversely, 
with minimal effort to perform HAI 
surveillance accurately, very few cases 
are apparent. Whilst this paradox 
probably exists for all forms of disease 
surveillance, I think it is especially 
problematic for SSI, as the cases 
occurring after discharge from hospital 
are hard to detect. This surveillance 
effort-paradox is illustrated in figure 7-1, drawn from work done in the UK by the Health 
Protection Agency on developing SSI surveillance after Caesarean sections. In this figure 
where each point represents one hospital trust, there is a clear correlation between the 
percentage of Post Discharge Questionnaires (PDQ) returned in each hospital (which I posit 
approximates an institutional “level of effort”) and the measured SSI rate. In this example 
the problem was thought to have arisen because the surveillance system was newly- 
implemented and had not yet established mechanisms to account for differential 
questionnaire return rates -  but it seems likely that even in well-established HAI surveillance 
systems, the same issue is likely to exist.
The problem that arises from this paradox is that if the level of "surveillance-effort" 
varies between the intervention and control arms of a comparative study, or between sites in a
F ig u re  7-1: A s s o c ia t io n  b e tw e e n  Q u e s t io n n a i r e s  re tu rn ed  a n d  
S S I  rate, c o u r t e s y  o f  C a th e r in e  W lo ch ,  H PA,  U K
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multi-centre surveillance program, this in itself could be sufficient to lead to an apparent 
effect of the intervention or differential rate between centres, leading to bias in the study 
This bias might occur quite subtlety -  an investigator who puts much effort into introducing a 
change in a hospital practice might unconsciously relax the effort put into their surveillance 
leading to an apparent success of the intervention. I was very conscious of this risk when 
organising the change in antibiotic prophylaxis policy at Thika Hospital and was careful to 
make no changes to the staffing or procedures of the SSI surveillance team at any point 
during the surveillance. However, it was obviously impossible to keep myself or the SSI 
surveillance staff blinded to the fact that a significant change in a relevant clinical practice 
had taken place -  could we have unknowingly altered our approaches to surveillance alter 
implementation of the change in policy? I found no evidence of such changes in terms of 
coverage of post-operative follow-up (telephone contact remained high throughout the study) 
or thresholds for diagnosis of SSI (I reviewed all patients diagnosed with SSI), hut I wasn't 
able to sustain the same level of personal oversight for the SSI surveillance for the whole 
period of working in Kenya. One alternative approach to this issue would have been to 
conduct this work as a randomised double-blinded trial -  but as there is no doubt that pre­
operative antibiotic prophylaxis is superior to post-operative antibiotic use, I feel that it 
would clearly have been unethical to conduct such a trial.
Nosocomial bacteraemia is a tare outcome to work with in an epidemiological study and 
requires a well-functioning
microbiology service -  but it has the 
major advantage of being an 
objectively defined outcome.
Collecting sufficient data to make 
useful epidemiological conclusions 
on this subject requires technical 
expertise in several domains and a 
considerable investment of time and 
money. I was very fortunate to be in 
the position to analyse a 7-year 
period of high-quality clinical and
laboratory data without having been in .„ . .„ , ...... ..  estaottshmem of the surveillanc
-  this was a very satisfying analysis to conduct. In some ways, nosocomial bacteraemia is a
98
C haptcr 7: Discussion and conclusion
much better epidemiological outcome to work with than SSI -  there is little doubt about the 
seriousness of the illness nor of the
diagnostic objectivity in the vast 
majority of these cases. The dramatic 
changes in the risk of nosocomial 
bacteraemia observed during the course 
of the surveillance (figure 7-2), 
exemplifies my earlier observation about 
the “surveillance-effort paradox” -  but 
more post-admission blood cultures 
were being taken in later years (figure 7- 
3), which partially may partially explain
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Figure 7-3: Trend in post-admission BC collection
By contrast to the work on SSI and nosocomial bacteraemia, the MRSA study used no 
surveillance data and made use of a very clear outcome state (the presence of the mecA gene 
in S.aureus isolates), which could be tested phenotypieally with reasonable accuracy in the 
laboratory at Thika Hospital and was subsequently definitively confirmed by microarray 
testing. The obvious drawback of this outcome state was that it was actually quite rare, or at 
least much rarer than anticipated, which limited the scope of the epidemiological 
investigations that could be performed with resulting data.
7.3. Challenges in II system construction for HAI surveillance
One of the important decisions to make when designing any surveillance program is to 
determine how the data being collected will be inputted, handled, stored and accessed by a 
computer system. Although generic database packages (e.g. Microsoft Access, Fllemaker 
Pro) can be used for this purpose and several commercial software packages specifically 
designed for HAI or SSI surveillance also exist, for the SSI surveillance that I set up at Thika 
Hospital, I made the decision to create a modular extension onto a pre-existing piece of 
locally-written software that was already in use at Thika Hospital in 2010. The pre-existing 
system, called the Integrated Medical Records System (IMRS) was used on a within-hospital 
network of computers in the paediatric, maternity, laboratory and administrative buildings 
and the network progressively expanded to other areas also. This system was designed
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installed and administered by another KEMRI- Wellcome Trust Research Programme 
(KWTRP) scientist working in Thilca Hospital (Moses Ndiritu) whose work focussed on 
paediatric pneumococcal bacteraemia. A central hospital server hosted the IMRS system and 
performed daily back-ups o f its databases. Other software used by the hospital primarily for 
financial purposes also operated on the same network and server. I organised for extension o f 
the physical network in the hospital to operating theatres and surgical wards and employed a 
programmer (Geoffrey Mimano) to write the “surgical” extension module o f  IMRS.
The extension module o f  the IMRS was known as ESURG. The whole oflM R S was 
coded using the PHP scripting language, the Zend framework for the "front-end" user- 
interactions and server components and a MySql database system for data management 
MySql was originally selected since it is an open-source, robust data management suite that is 
able to handle large data sets. Computers set up to use the IMRS in the hospital system ran on 
the Ubuntu operating system, which is also open-source and generally extremely resistant to 
viruses and other malware. The actual interactions between computer tetminals and the main 
database on the central server were mediated via web-browser software (Mozilla Firefox), 
although data were only transmitted within the hospital intranet and never over the wider ' 
internet. Thus all the components o f  the surveillance system made use o f  freely available 
software which were able to operate on low-speciftcation computers, and provided excellent 
data security in a system that was highly resistant to virus attack, power failure and slow or 
intermittent internet access -  all significant daily risks in Kenya. Additionally, it was possible 
to design some simple reporting components to produce live summaries o f  data. More
complex analyses could be perfotmed after downloading a copy of the database to an external
machine running specialist data-analysis software.
The drawbacks o f using this bespoke, locally-programmed distributed database 
system for surveillance were as follows:
- the time and expense o f developing this ESURG software were considerable: an 
experienced and skilled programmer took 4 months o f full-time work to write a basic package 
for collecting data for SSI surveillance, and then a further 2 months to introduce and trouble­
shoot this software. Part o f the difficulty arose from the need for the second programmer to 
understand how the first programmer had configured the layout o f  the original IMRS system 
and then to understand how to frame the SSI surveillance system within the same format -
the important lesson being that any newly designed system needs adequate documentation
when they are being designed and implemented.
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- as the system was designed using a specific software language (PHP) and format (Zend 
frameworks), it was impossible for me (with only a basic understanding of computer 
programming) to make adjustments to the system as the surveillance progressed, once the 
programmer had completed his 6 month contract.
- making use o f a multi-computer system operating over the shared space o f the hospital 
intranet and hosted on the hospital server, rather than using a single stand-alone machine 
under my control, gave me a de facto responsibility to ensure adequate maintenance o f the 
hospital intranet, regulation of internet-usage and the upkeep (and eventual replacement) o f 
the hospital server. Whilst there may have been some benefits o f having a “shared stake” in 
upkeep of the hospital IT systems, this oversight was very time-consuming and expensive to 
perform.
On balance, I think it would almost certainly have been better to have used a commercial- 
available piece of dedicated SSI surveillance software, which could have been used with 
multiple terminals across the hospital intranet. I think this would have been preferable to 
batched double-entry of paper forms by data-entry clerks as this would distance the clinical 
members o f the surveillance team from the resulting data -  my sense is that well-motivated 
clinical staff are better at controlling errors than software validation scripts.
7.4. Novel descriptions of bacterial diseases and their plausibility
Two o f the projects described in this thesis (nosocomial bacteraemia and MRSA) make, 
to some extent, a new description of the rate of a form of bacterial disease in an African 
context; by contrast, SSI is already well-known to be a considerable problem in many low- 
income countries. How plausible are these two new descriptions in epidemiological and 
microbiological terms? Firstly, considering the three classic forms o f epidemiological error -  
bias, confounding and random error -  we can eliminate each o f these on the following 
grounds. With regard to bias, as large proportions o f the target populations in both studies 
were sampled systematically, it seems unlikely that bias relating to inclusion in studies could 
be playing a major role. With regard to confounding, although both of these studies did find 
associations between the particular form of disease and a clinical exposure (MRSA with 
burns; nosocomial bacteraemia with blood transfusions), whether or not these associations 
were confounded by other variables is irrelevant to the question of the underlying rate of 
occurrence o f the disease. With regard to random error, the overall number o f cases in the 
nosocomial bacteraemia study was sufficiently large to give quite narrow confidence
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intervals, though this was not the case in the MRSA study -  in the latter study we might have 
considerably under or over estimated the scale of this disease. With regards to 
microbiological sources of error, these seem unlikely in either project as both studies made- 
use of laboratories that were working to very high internal and external quality control 
standards. Furthermore, within both studies, there were several pieces of corroborating 
evidence to back up the reliability of the primary identification of the bacterial pathogens- in 
the nosocomtal bacteraemia work, there was clear epidemiological evidence of both 
morbidity and mortality burdens imposed by disease whilst in the MRSA study, the 
microatray studies supported the primary phenotypic identifications. In addition to the 
internal reliability of both of these studies, other scientific research, albeit on a smaller scale 
or in a different format, lends further plausibility to these novel descriptions; in the work ' 
relating to nosocomial bacletaentia, we referred several previous reports o f outbreaks of 
nosocomtal in sub-Saharan Africa and in the MRSA field, there is clearly previous evidence 
to suggest that this pathogen is widely dispersed in the region.
7.5. Antibiotic resistance -  the coming storm in African hospitals?
Antibiotic resistance and antibiotic stewardship are high 
profile topics at this time -  World Health Day in 2011 was 
devoted to this issue (Figure 7-4). From what we know in 
high-income settings, the extent of antibiotic resistance is 
inversely correlated with the overall consumption of 
antibiotics in the population -  this is probably most famously 
illustrated by an ecological study observing antibiotics 
resistance rates in different European countries (1) As 
hospitals are inevitably the locations were antibiotic use is 
most highly concentrated, selective pressure will almost 
invariably make these foci of resistance. Little is known
about the overall extent of antibiotic resistance in hospital populations In developing 
countries, but wotryingly, extensive antibiotic resistance has often been uncovered when 
Inpatients have been transferred from hospitals i„  developing countries to high-income 
settings -  most notoriously, with the discovery of the NDM-I allele of the bla gene following 
the transfer of a patient from India to Sweden (2). Auecdolal reports from colleagues working 
in private hospilals in Mombasa and Nairobi suggest that same combination o f circumstances 
that appear to have led .0 the generation and widespread environmental distribution o f novel'
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Figure 7-4: Poster from 
World Health Day 2011
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antibiotic resistance genes in New Delhi (3) are probably also present in large cities in Kenya. 
Currently, in the public-service hospitals such as Thika Hospital, my sense is that the 
extremely limited supply of most advanced antibiotic agents is probably the most effective 
restriction on their usage -  but this is unlikely to remain the case indefinitely.
All three strands o f my work in nosocomial infection had a close relationship with issues 
o f  antibiotic use and resistance. In the work relating to nosocomial bacteraemia, we made a 
decision not to include any report of antibiotic resistance amongst the isolates identified when 
we submitted this work for publication. Further analysis o f these isolates is currently ongoing 
-  preliminary analysis o f surveillance data had suggested a marked difference in the extent of 
antibiotic resistance between isolates of the same species acquired in the hospital and the 
community.
Investigation o f the spread o f antibiotic resistance between continents has been greatly 
facilitated by use o f DNA sequencing technologies -  the spread o f the MRS A ST239 clone 
has been investigated in some detail, although not in Africa (4). We hope to conduct whole 
genome sequencing of MRS A isolates from Thika Hospital with the Sanger Institute in the 
near future and aim to use this approach to place these East African isolates in an 
intercontinental evolutionary tree o f MRSA ST239 isolates. Hopefully we may also obtain 
some insights as to why this organism was so rarely being transmitted (other than amongst 
patients with bums) in Thika Hospital.
The work relating to use o f antibiotic prophylaxis raises an interesting and (to my 
knowledge) unanswered question: what is the importance of antibiotic resistance when an 
antibiotic is being used for prophylaxis purposes? This was of great relevance when we were 
selecting drugs to use for antibiotic prophylaxis in Thika Hospital as ampicillin, which was in 
many other respects an ideal agent, was known to have widespread drug resistance in disease- 
causing isolates in Kenya. The role o f  antibiotic prophylaxis in surgery is to reduce the 
bacterial innoculum introduced into the operation wound at the time of surgery -  it is not 
intended to entirely sterilize the patient, but just to sufficiently reduce the number o f bacteria 
so that the immune system can deal with any remaining organisms. The important 
characteristic o f this bacterial innoculum is that it is a heterogeneous population of bacteria, 
derived from a mixture of the patient’s own microflora, plus some from the operating theatre 
environment and the operating team. This means that antibiotic resistance in this innoculum 
is also likely to be heterogeneous -  and the variation in bacterial species will also mean that 
different agents are useful against different subsets o f the bacterial population. In my mind,
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this situation probably means that even i f  a moderate proportion o f bacteria in the bacterial 
innoculum do have resistance against the agents used in prophylaxis, the drugs for 
prophylaxis should still be effective against the remainder. An increasing proportion of 
resistance in the innoculum might then be expected to lead to a gradual diminution o f the 
effectiveness of prophylaxis, but this effect might be non-linear. We should also bear in mind 
that use o f prophylaxis against a partially resistant bacteria population will select in favour of 
resistant strains, making it more likely that any SSI that do develop at resistant to this agent. 
This situation is totally different to the effect o f  antibiotic resistance in treating an established 
bacterial infection -  in an infection, the bacterial population is largely homogenous, and the 
response to antibiotic treatment (if delivered in the appropriate doses and duration) will be 
either all or nothing. As far as I am aware, the effect o f increasing proportions o f antibiotic 
resistance on the effectiveness o f antibiotic prophylaxis has not been explored, either in 
animal or clinical studies. As antibiotic resistance becomes ever-more widespread, this would 
be a useful question to investigate.
7.6. W hy  so little  Staphylococcus aureus?
It remains a puzzle to me why carriage of MRSA in Thika Hospital was so rare and 
almost entirely confined to patients with bums -  what could have prevented this organism 
from spreading to other patients in these crowded wards where healthcare workers (in my 
experience) rarely washed their hands? In many respects, these were ideal circumstances for 
frequent cross-infection of patients with MRSA, yet carriage was extremely uncommon. My 
suspicion is that there is something fundamentally different about the biology of the 
organism-host interactions for S.aureus carriage in this setting to that seen in high-income 
countries. The main reason for believing this is that we found an overall S.aureus carriage 
rate o f only 9% - a more typical value in a “western” setting would be around 25%, although 
this appears to be declining over time (5) - and researchers working in Coast Province of 
Kenya had also found S.aureus nasal carriage to be rare (personal communication, Donald 
Akech, KEMRI-Wellcome Trust). In the work relating to SSI, out o f the wound samples 
where a likely pathogen was identified by the microbiology laboratory in Thika Hospital,
S aureus only accounted for about 25% of these pathogens -  a much smaller proportion than 
is seen in high income countries, but consistent with the (small number) o f high quality 
studies o f SSI microbiology done in the region (refs needed). A review o f studies of 
community-acquired bacteraemia in Africa found S.aureus to account for 9.5% of these 
infections (6), similar to the figure o f 13% that we found in Kilifi. In bacteraemia, it is hard to
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compare proportions o f pathogens as whether or not possible contaminants (such as 
Coagulase-negative Staphylococci) have been excluded exerts a large influence on the 
proportions and is very variable between studies.
On this basis, it does seem possible that S.aureus might be less prevalent in carriage and 
as a cause o f disease in East Africa than in other regions o f the world -  are there plausible 
explanations for this? Regional and temporal variation in rates of bacterial carriage is not 
unusual -  paediatric S.pneumoniae carriage is much more common in low-income countries 
and carriage was observed to decline in high-income countries over the course o f the 20th 
century. Between S.aureus, other epidermal micro-organisms and the human host, there is a 
wide range o f “push” and “pull” forces that determine carriage o f bacteria (5) - 1 cannot say 
which of these is playing the important role here. Perhaps there is a good evolutionary reason 
why regional differences in the human skin-surface microbiome occur. For example, the 
populations of enteric bacteria from rural Malawians and Amazonian Indians tend to be 
different to those o f US residents of similar ages, and have more genes that process (and 
release) important carbohydrates and micronutrients (7), which seems an obvious symbiotic 
adaptation to local conditions -  regional variations in the skin-surface microbiome could well 
have a similar co-evolutionary explanation.
7,7. How can  we influence n a tio n a l infection co n tro l policy?
In terms o f producing published national policy documents relating to nosocomial 
infections, Kenya is doing rather well: paired National IPC Policy and Guidelines were 
published in December 2010 and these documents contain many sensible provisions for 
government hospitals - any other low-income countries wishing to develop such policies 
would do well to use the Kenyan documents as a starting point. These documents cover 
issues relating to antibiotic prophylaxis in surgery (several times), spread o f drug-resistant 
organisms and describe the possibility o f hospital-acquired bacteraemia. On the issue o f 
antibiotic prophylaxis, these documents are very clear that pre-operative prophylaxis is 
preferable to post-operative use -  hence making it quite impossible to consider a randomised 
trial on this question. The policy documents establish that tackling HAI is a priority for 
everyone working in hospitals and encourage the open acknowledgement that these types of 
infections do occur and can be prevented.
One issue that may present a substantial obstacle to establishing the need for national 
infection control policies in countries in sub-Saharan Africa is the extremely limited number
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o f estimates of the burden of nosocomial disease, in terms of deaths, disability or economic 
impacts. Producing such estimates is difficult as most studies o f nosocomial diseases in the 
region derive from a single institution and without standardised methods or definitions across 
a representative series o f sites, it is hard to produce a geographically representative estimate. 
Without an appreciation of the “large-scale” impacts o f this issue, formulation or 
enforcement of infection control policy, whether at the national or local level, is likely to be 
weak.
There is actually good reason to think that the regional burden of nosocomial infection in 
Africa could be a considerable health problem. If we take nosocomial bacteraemia -  which is 
a single rare-but-severe form of HAI -  and multiply the risk-per-admission and the mortality- 
per-case that we found in Kilifi Hospital by the local average rate of hospital admission 
(approximately 1 in 20 per year for under 5s) and the population of under-5s in sub-Saharan 
Africa (2005 UN data), this brings a very basic estimate o f approximately 20,000 deaths per 
year for under-5s in sub-Saharan Africa. This estimated number of deaths, albeit very crude, 
would put the disease on a par with African Trypanosomiasis - how much larger would the 
problem be if  all forms o f HAI across all ages were included? One useful future piece of 
future work would be to apply the approaches used in Kilifi Hospital across a larger number 
o f sites in Africa to obtain an estimate with the appropriate degree o f representation of 
different areas of the continent.
7.8. W h a t changes clin ical p rac tice?
Although there extremely limited research into improving hospital infection control 
practices in low-income countries, lessons on getting research into practice can be drawn 
from other fields o f health systems research. One Kenya-based group focussing on paediatric 
care has been very productive in recent years, recently concluding a major project based on 
evaluation o f the implementation o f training and guideline programs on improving the quality 
o f acute paediatric care (8-9). Interesting reports from this group include a report o f using 
clinical guidelines to achieve an improvement in the performance of clinicians in individual 
tasks, although there were no improvements in the performance in tasks requiring sustained 
efforts o f teams (10). Another study described some evidence for a reduction in inappropriate 
antibiotic prescribing as a result o f a multi-faceted intervention over an extended period (11). 
A common theme across much o f the work from this group is the need for close involvement 
with clinicians over an extended period and for delivery o f training and guidelines in a 
variety o f modalities, primarily performed face-to-face.
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In my studies, getting clinicians in Thika Hospital to change any of their practices -  
whether documentation standards for surgical procedures or use of antibiotic prophylaxis -  
was difficult. For many clinicians, continuing to do what had always been done was the 
preferred option regardless of evidence presented and any suggestion that a change in 
practice might achieve better results was met with intense scepticism. 1 used a wide variety of 
approaches to overcome this resistance to change: seeking management-level support and 
endorsement at every step; recruiting departmental advocates for the desired change; whole­
hearted engagement in discussions over the minutiae of the planned change; intensive and 
sustained educational activities for all hospital staff in a variety of formats regarding the 
planned changes; providing feedback to individuals and departments about adherence to the 
agree changes. Ultimately, one positive aspect of this organisational resistance to change was 
that once a change (in this case, the different format of antibiotic prophylaxis use) had 
become the norm, this subsequently remained the standard practice long after my surveillance 
project finished. The same cannot be said of standards of documentation or activities of the 
Hospital Infection Prevention and Control Committee -  these appear to have reverted to their 
former state after I left Thika Hospital. For achieving lasting changes in Infection Control in 
Kenyan hospitals, I think there is no substitute for ongoing hard work at the local level by 
highly-motivated specialists.
New technology can be instrumental in driving changes in 
healthcare and for Infection Control in developing countries the 
introduction of alcohol hand-rub is an enormously important 
innovation. In Kenya, it was exciting to see the start of local 
manufacture and marketing of such a product (fig 7-5 -  courtesy of 
James Kimotho, KEMRI-CDC) while I was based there, although 
the evidence-base unpinning the effectiveness of this product in 
preventing transmission of HA1 is currently somewhat scanty. 
Alcohol hand-rubs were in occasional use at Thika Hospital at the 
time I was working there -  though it seems unlikely to me that their 
use was sufficiently widespread to be substantially impeding the 
transmission of MRSA.
HAI research in high-income countries is far ahead of work in African settings, so other 
pragmatic research in adapting processes or methods from high to low-income settings is 
likely to be fruitful for some time to come: two examples are radio-frequency ID tags and
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checklists. Radio-frequency ID (RFID) tags are starting to be used in hospitals in high- 
income countries for tracking the physical movements o f hospital staff members, including 
their visits to patient bedside areas and to hand-washing basins -  these could easily be 
deployed in low-income settings on a research-basis to investigate the spread o f infections in 
hospital wards. Checklist also a current area o f much interest: this approach to complex tasks 
has some merits for adaptation to medical procedures in low-income setting where much 
routine work is delegated from doctors to less expensively trained nurses other clinicians. A 
checklist relating to childbirth was recently found to be very effective in improving process 
measures in an Indian setting (12) -  but I am not aware o f any checklist-based studies 
conducted exclusively in African hospitals. Interestingly, one o f the most influential studies 
investigating the use of a general surgical checklist involved eight (extremely diverse) 
hospital sites around the world, including one hospital in Tanzania (13). The report o f the 
study anonymised the hospital sites, but it was clear that one o f the hospitals made an 
enormous improvement in the appropriate use o f antibiotic prophylaxis as a result o f 
introduction o f the surgical checklist, which probably accounted for much o f the overall 
benefit reported in the study.
7.9. A discussion on Infection  C o n tro l in A frica
At the time I first arrived at Thika Hospital in 2009, there was no active Hospital 
Infection Prevention and Control Committee (HIPCC) -  this had lapsed after the sudden 
death o f the member of staff who had led this. As part o f my involvement with Thika 
Hospital, I chaired the HIPCC for the time I was based at Thika Hospital, which primarily 
involved holding monthly meetings to discuss current Infection Control issues. Major IPC 
achievements included writing and launching a Hospital Infection Control Policy, getting an 
Infection Control professional to sit on the Hospital Management Team and getting a (small) 
budgetary allocation for infection control work in the hospital. We conducted various training 
sessions and presentations to hospital staff members, and were invited to talk at hospitals 
elsewhere in the District However, we never managed to achieve having a full-time infection 
control nurse permanently employed by the hospital -  despite the Ministry o f Medical
Services mandating (in mid-2011) that a hospital o f this size should have at least two full­
time nurses in this role.
Beyond Thika Hospital, it was apparent to me that Infection Control was an issue that 
many clinicians, policy makers and researchers in Kenya were beginning to take seriously.
As previously mentioned, in 2010, the Kenyan Government launched a National Infection
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Control Policy and accompanying Guidelines and following this in 2011, a National Infection 
Control secretariat was formed by the Ministry of Medical Services to look into the 
implementation of the Infection Control Policy. As part of the process of raising awareness 
about this work, I worked with several colleagues including Linus Ndcgwa and Daniel 
Kimani at the KEMRI-Centres for Disease Control (K.EMR1-CDC) and many others to run an 
Infection Prevention and Control conference, which was held in Mombasa in November 
2011. There were 25 scientific presentations and approximately 90 attendees, including 
several high-level Ministry representatives. We received several sizeable donations from 
commercial organisations and the conference turned a small profit, although substantial 
“start-up” funding had been provided by KEMRI-CDC. 1 was the Scientific Chair of this 
conference, and in the course of the meeting, we presented both the work done in Thika 
Hospital regarding SSI and the work in Kilifi Hospital regarding nosocomial bacteraemia -  
these were both received with great interest.
Figure 7-6: Attendees at the IPNET-K conference -  
W hitesands Hotel, Mom basa, 28-29 November 2011
7.10. Conclusion -  M AI monitoring as an index of healthcare quality 
In many important respects, rates of hospital-acquired infections and the extent of efforts 
to prevent their occurrence are most usefully considered as a marker of quality in a health 
system. As the work of this thesis has shown, their occurrence, if unmanaged, is inevitable, 
but efforts to minimize or prevent their occurrence can be highly effective if local 
practitioners engage with the issue. Rates of HAI disease, if properly measured over an 
extended period, are sensitive indicators of quality-of-care in the institution. However, as the
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work of this thesis has shown, the measurement o f HAI in a low-income setting is itself a 
complex and demanding task. A marker o f any effective healthcare system is that they 
perform continuous self-assessment and improvement through internal audit cycles -  in a 
well-run hospital, the more common forms of HAI can be detected and prevented by internal 
auditing processes in the system. Thus if HAI are an indicator of the general quality of a 
health system (14), reducing their occurrence in low-income countries will require system- 
wide improvements above and beyond any steps being taken to purely tackle the HAI 
symptoms o f the underlying systemic problems.
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